|
1 |
|
00:00:00,610 --> 00:00:05,670 |
|
ุงููู ุงูุฑุญู
ู ุงูุฑุญูู
ุญุถุฑุชูุง ุงูููู
ุนู tumor |
|
|
|
2 |
|
00:00:05,670 --> 00:00:12,070 |
|
immunology ูู
ุดุงุฑุฌ |
|
|
|
3 |
|
00:00:12,070 --> 00:00:17,990 |
|
ุฌูุงุฒ ุงูู
ูุงุนุฉ against tumor cell ุทุจุนุง ูููุง ุจูุนุฑู ุงู |
|
|
|
4 |
|
00:00:17,990 --> 00:00:27,770 |
|
tumor cell has antigen on their surface ูุจุงูุชุงูู |
|
|
|
5 |
|
00:00:27,770 --> 00:00:36,130 |
|
these antigens are foreign antigens ูุจุงูุชุงูู |
|
|
|
6 |
|
00:00:36,130 --> 00:00:43,430 |
|
ุงูุฌุณู
ุจูุนุชุจุฑูุง as foreign cells ููุงุจุฏ ู
ู ุงูู ูุดูุฑ |
|
|
|
7 |
|
00:00:43,430 --> 00:00:54,770 |
|
ููู ุชุตุฏู ููุฐู ุงูุฎูุงูุง ุงู |
|
|
|
8 |
|
00:00:54,770 --> 00:00:55,730 |
|
tumor specific |
|
|
|
9 |
|
00:00:58,510 --> 00:01:02,690 |
|
transplantation antigen ูู ุงูุงูุชุฌูุงุช ุงูุชู ุชุธูุฑ ุนูู |
|
|
|
10 |
|
00:01:02,690 --> 00:01:07,830 |
|
ุณุทุญ ุฎูุงูุง tumor ููุฌุฏููุง |
|
|
|
11 |
|
00:01:07,830 --> 00:01:12,390 |
|
in variety of animal species tumor specific |
|
|
|
12 |
|
00:01:12,390 --> 00:01:17,830 |
|
transplantation antigen ูุฃููู
ููุฏุฎููุง ุนูู ุชุนุฑููุงุช ูุฐู |
|
|
|
13 |
|
00:01:17,830 --> 00:01:23,870 |
|
ุงูุงูุชุฌูุงุช tumor antigen ู
ู
ูู ุชุดุชุฑู ู
ุน ุงู tumor |
|
|
|
14 |
|
00:01:23,870 --> 00:01:24,290 |
|
cell |
|
|
|
15 |
|
00:01:28,020 --> 00:01:33,300 |
|
ุชุดุชุฑู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู |
|
|
|
16 |
|
00:01:33,300 --> 00:01:35,480 |
|
ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
|
17 |
|
00:01:35,480 --> 00:01:35,880 |
|
ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู |
|
|
|
18 |
|
00:01:35,880 --> 00:01:39,600 |
|
ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
|
19 |
|
00:01:39,600 --> 00:01:43,560 |
|
ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู |
|
|
|
20 |
|
00:01:43,560 --> 00:01:44,340 |
|
ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
|
21 |
|
00:01:44,340 --> 00:01:50,080 |
|
ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู ู
ุฎุชูู ุจุดูู |
|
|
|
22 |
|
00:01:50,080 --> 00:01:55,800 |
|
ู
ุฎุชูู ุจุดูู Demonstration of Tumor-Specific |
|
|
|
23 |
|
00:01:55,800 --> 00:01:59,980 |
|
Antigen of Chemically Induced Tumor ุฃูู ู
ุง ุงูุชุดููุง |
|
|
|
24 |
|
00:01:59,980 --> 00:02:06,400 |
|
ุฑุฏุฉ ูุนู ุฌุณู
ุงูู
ูุงุนูุฉ ูู ุงู .. against tumor |
|
|
|
25 |
|
00:02:06,400 --> 00:02:15,560 |
|
antigen ู
ู ุฎูุงู ุชุฌุฑุจุฉ ุนูู ุงู mice ุงูุชุฌุฑุจุฉ ูุงูุช |
|
|
|
26 |
|
00:02:15,560 --> 00:02:25,710 |
|
ูุงูุขุชู ุนู
ููุง tumor ูู ุงูู mouse ู
ู ุฎูุงู ุฏูู ุงู |
|
|
|
27 |
|
00:02:25,710 --> 00:02:32,450 |
|
skin of the mouse by methyl chloranthrene ูุจุงูุชุงูู |
|
|
|
28 |
|
00:02:32,450 --> 00:02:38,730 |
|
ุงุณุชููู ุงู tumor they excise the tumor ูุนู
ููุง ู
ูู |
|
|
|
29 |
|
00:02:38,730 --> 00:02:44,990 |
|
tumor cell suspension ูุจุนุฏ ููู they inject the |
|
|
|
30 |
|
00:02:44,990 --> 00:02:50,220 |
|
prepared tumor cell into a new mouseุฃูุถุง ุชูููุช |
|
|
|
31 |
|
00:02:50,220 --> 00:02:57,060 |
|
tumor , they excise the tumor ู they challenge the |
|
|
|
32 |
|
00:02:57,060 --> 00:03:02,660 |
|
mouse with the same tumor ูุฌุฏูุง ุงูู there is no |
|
|
|
33 |
|
00:03:02,660 --> 00:03:03,760 |
|
tumor growth |
|
|
|
34 |
|
00:03:07,990 --> 00:03:11,330 |
|
Injection of prepared tumor cell into a new |
|
|
|
35 |
|
00:03:11,330 --> 00:03:17,910 |
|
mouse Excise a growing tumor ุฃูุถูุง Challenge with |
|
|
|
36 |
|
00:03:17,910 --> 00:03:22,510 |
|
different tumor cells With tumor cells ูุญู ุงูู |
|
|
|
37 |
|
00:03:22,510 --> 00:03:30,630 |
|
tumor will grow ุจุจุณุงุทุฉ ุฎุทูุงุช ุงูุชุฌุฑุจุฉ ูุงูุช ูุงูุขุชู |
|
|
|
38 |
|
00:03:30,630 --> 00:03:36,070 |
|
ุฐูุฑูุงูุง ุฅูู
ุง ูุดุฑุญูุง ุนูู ุตูุฑุฉ ูุงูุขุชู ูู ุนุจุงุฑุฉ ุนู |
|
|
|
39 |
|
00:03:36,070 --> 00:03:40,500 |
|
mouse with chemically carcinogenic induced tumor |
|
|
|
40 |
|
00:03:40,500 --> 00:03:48,180 |
|
ุฏูุงููุง ุฏู ูู ุงู skin by ash ุงููู ูู carcinogenic |
|
|
|
41 |
|
00:03:48,180 --> 00:03:53,940 |
|
agent ูุชููู ุงู cancer ุฃุฎุฏูุงูุง ู ุนู
ููุง ู
ููุง tumors |
|
|
|
42 |
|
00:03:53,940 --> 00:04:00,240 |
|
cell suspension ูุทุจุนุง |
|
|
|
43 |
|
00:04:00,240 --> 00:04:08,550 |
|
ุญูููุง ูููุนู ู
ุงุดู the same the same mouse ุญูููุง |
|
|
|
44 |
|
00:04:08,550 --> 00:04:17,410 |
|
ุงูู ุซู
ุฑุฌุนูุง ุชุงูู ูุญุทููุง ุงูู tumor cell ูุฌุฏูุง ุงู |
|
|
|
45 |
|
00:04:17,410 --> 00:04:26,890 |
|
ุงู tumor cell ูู
ุชูู
ู ุฏููู ุนูู ุงู ุงู tumor cell |
|
|
|
46 |
|
00:04:26,890 --> 00:04:31,490 |
|
ุงููู ุฏุฎูุช ุชุตุฏู ููุง ุฌูุงุฒ ุงูู
ูุงุนุฉ ูููู ุงู vector |
|
|
|
47 |
|
00:04:31,490 --> 00:04:37,790 |
|
cell ุนู
ููุง ุงู tumor ู
ุฑุฉ ุชุงููุฉ ุงู tumor has been |
|
|
|
48 |
|
00:04:37,790 --> 00:04:44,210 |
|
rejected the same cell ูู tumors ุงูุญูููุง for |
|
|
|
49 |
|
00:04:44,210 --> 00:04:57,290 |
|
syngeneic mice ุจุณ ูู ูุฐู ุงูุญุงูุฉ ูู
ุง ูู
ุง ูุนูู ุนู
ููุง |
|
|
|
50 |
|
00:04:57,290 --> 00:05:04,330 |
|
ุชููู ุงู tumor ููู ูู
ุงุฐุงุ ูุฃูู ูู
ูุฑู ุงูู tumor ู
ู |
|
|
|
51 |
|
00:05:04,330 --> 00:05:09,650 |
|
ูุจู ูุฐุง ุงูู mouse ููู ูู ุฃุฎุฏูุง ุงูุฎูุงูุง ุงูู
ูุงุนูุฉ |
|
|
|
52 |
|
00:05:09,650 --> 00:05:12,950 |
|
ุงูุชู ุชุชูููุช ุฌูุงุฒ ุงูู
ูุงุนุฉ ุงุดุชุบู ูุฃุฎุฏูุง ุงูุฎูุงูุง |
|
|
|
53 |
|
00:05:12,950 --> 00:05:18,430 |
|
ุงูู
ูุงุนูุฉ ุงูุชู ุชูููุช ุนูุฏู ูุญูููุง ูู fire ุชุงูู ู
ู |
|
|
|
54 |
|
00:05:18,430 --> 00:05:22,770 |
|
ุฎูุงู ุฏู ูู adoptively transfer T cell ุฎุฏูุง ุงูุฎูุงูุง |
|
|
|
55 |
|
00:05:22,770 --> 00:05:24,790 |
|
ุงูู
ูุงุนูุฉ ุงูู
ุชู
ุซูุฉ ุจุงูู T cells |
|
|
|
56 |
|
00:05:28,050 --> 00:05:31,230 |
|
ุนู
ููุง challenge ูุนูู ุงุนุทููุง .. ููููุง tumor ุนูุฏู |
|
|
|
57 |
|
00:05:31,230 --> 00:05:35,490 |
|
ู
ุฑุฉ ุชุงููุฉ ูุนูู ููุงูู ุงู tumor has been eradicated |
|
|
|
58 |
|
00:05:35,490 --> 00:05:41,810 |
|
ุจู
ุนูู ูู
ุชูู
ู ูุฐู ุงูุฎูุงูุง ูุนูู ุงููุงุฑู ุงููู ุนูุฏู |
|
|
|
59 |
|
00:05:41,810 --> 00:05:44,970 |
|
tumor ูู
ุง ูุฎููุงู ุจุงูุงุฏุงุก .. ุจุงู .. ุจุงู .. ุจุงู team |
|
|
|
60 |
|
00:05:44,970 --> 00:05:51,170 |
|
for science ุงููู ุงุชูููุช ุนูุฏู ู
ุงุดู ูุฏู ูู ุนูู ุทูู |
|
|
|
61 |
|
00:05:51,170 --> 00:05:59,070 |
|
ุตุงุฑ ูู eradication ุงูุฃู
ูู ูู tumor ุงููู ู
ูุฌูุฏ ุฏููู |
|
|
|
62 |
|
00:05:59,070 --> 00:06:03,650 |
|
ุนูู ุงู ูู ุฌูุงุฒ ู
ููุง ูุงุนุฏ ุจูุดุชุบู ูุงูู ูู ุนูุงูุฉ |
|
|
|
63 |
|
00:06:03,650 --> 00:06:10,910 |
|
ู
ุซุจุชุฉ ุจูู ุงู immune response ู tumor cell tumor |
|
|
|
64 |
|
00:06:10,910 --> 00:06:17,930 |
|
immunology ูุฏููุง ูู ู
ุนุฑูุฉ ุงูุนูุงูุฉ ู
ุง ุจูู ุงู host |
|
|
|
65 |
|
00:06:17,930 --> 00:06:22,890 |
|
and tumor ุฃูุถูุง using the immune response to tumor |
|
|
|
66 |
|
00:06:22,890 --> 00:06:29,050 |
|
for diagnosis for prophylaxis and for therapy ูู |
|
|
|
67 |
|
00:06:29,050 --> 00:06:36,330 |
|
ุงูุงูุชุฌูู ุทุจุนุง ููููุฉ ุชูููููุง ุจุชุชู
ุฎูุงู mutation |
|
|
|
68 |
|
00:06:36,330 --> 00:06:42,550 |
|
genetic activation clonal amplification |
|
|
|
69 |
|
00:06:42,550 --> 00:06:48,910 |
|
chromosomal deletion and translocation ูููุง ุนุจุงุฑุฉ |
|
|
|
70 |
|
00:06:48,910 --> 00:06:53,730 |
|
ุนู ุนู
ููุงุช ุจุชุคุฏู ุฅูู mutation ูุจุงูุชุงูู ุจุชูููู ู |
|
|
|
71 |
|
00:06:53,730 --> 00:06:57,550 |
|
tumor antigen some tumor antigen are unique to |
|
|
|
72 |
|
00:06:57,550 --> 00:07:02,510 |
|
cancerous ูุนูู ููุท ู
ูุฌูุฏุฉ ุนูู ุฎูุงูุง ุงูุณุฑุทุงููุฉ ู |
|
|
|
73 |
|
00:07:02,510 --> 00:07:09,110 |
|
other ูู ู
ุดุงุจูุฉ ูู tumor cell antigen ูุนูู ู
ูุฌูุฏ |
|
|
|
74 |
|
00:07:09,110 --> 00:07:16,270 |
|
ุจุชุดุจูู ุงููู ูู ุงูุด ุงู ุงู normal cell antigen ููููุง |
|
|
|
75 |
|
00:07:16,270 --> 00:07:22,170 |
|
ุจุชุบุทู ุงูุฎูุงูุง ุชุบุทูุฉ ูุงู
ูุฉ ุฃู ุฌุฒุฆูุฉ and these |
|
|
|
76 |
|
00:07:22,170 --> 00:07:29,430 |
|
either by more expression on cancer cells ููู ุตุงุฑ |
|
|
|
77 |
|
00:07:29,430 --> 00:07:32,710 |
|
ููู expression ุฒูุงุฏุฉ ุนู ุงููุงุฒู
ููุฐู ุงูุงูุชูุฌูุงุช |
|
|
|
78 |
|
00:07:32,710 --> 00:07:38,010 |
|
ุนูู ุณุทุญ ุงูุฎููุฉ ุงูุณุฑุทุงููุฉ ูุงู
ุซูุฉ ุนูู ุฐูู ูุซูุฑ ู
ููุง |
|
|
|
79 |
|
00:07:38,010 --> 00:07:41,470 |
|
ุงู human epidermal growth factor ุงูุฑูุณุจุชูุฑ ุงููู |
|
|
|
80 |
|
00:07:41,470 --> 00:07:45,370 |
|
ุจูุฒูุฏ ุงู expression ุชุจุนู ูู ุงู ovarian and breast |
|
|
|
81 |
|
00:07:45,370 --> 00:07:51,190 |
|
cancer ุจุนุถ ุงู tumor antigen are present on |
|
|
|
82 |
|
00:07:51,190 --> 00:07:55,170 |
|
embryonic cell ููููุง ู
ุด ู
ูุฌูุฏุฉ ุนูู ุงู normal other |
|
|
|
83 |
|
00:07:55,170 --> 00:08:01,190 |
|
cells ุฒู ุงู oncofetal antigen ุทู
ูุฑ ุงูุงูุชุฌูู ูู
ูู ุฃู |
|
|
|
84 |
|
00:08:01,190 --> 00:08:05,850 |
|
ูููู ู
ุตุฏุฑ ู
ู ุงูุฌููุงุช ุงูู
ุชูุณุทุฉ ุฃูุถูุง ุฏููู ุนูู ุงูู ูู |
|
|
|
85 |
|
00:08:05,850 --> 00:08:10,610 |
|
ู
ูุงูุน ุญุฑุงุฑุฉ ููุชุบููุฑ ูููุงู |
|
|
|
86 |
|
00:08:10,610 --> 00:08:11,710 |
|
ูููู ู
ู ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
|
87 |
|
00:08:11,710 --> 00:08:12,030 |
|
ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
|
88 |
|
00:08:12,030 --> 00:08:14,290 |
|
ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
|
89 |
|
00:08:14,290 --> 00:08:14,990 |
|
ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
|
90 |
|
00:08:14,990 --> 00:08:15,510 |
|
ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ ุนู
ููุฉ |
|
|
|
91 |
|
00:08:21,440 --> 00:08:24,420 |
|
ุงูุชู ุชุณุจุจ ูู ุชุญููู ุงู tumor ุจุดูู ุฎุงุทุฆ ู
ุซู ุงูู |
|
|
|
92 |
|
00:08:24,420 --> 00:08:30,680 |
|
Ultraviolet ูุงูู X-ray ุฅุดุนุงุนูุฉ ูุงุฑุณูููุฌูู ูู
ูู ุฃู |
|
|
|
93 |
|
00:08:30,680 --> 00:08:35,840 |
|
ูุณุจุจ ููู ุชุญููู ููููู ูุงุฑุณูููุฌูู ูุนู
ู ุชุญููู ููููู |
|
|
|
94 |
|
00:08:35,840 --> 00:08:42,000 |
|
ูุฌููุงุช ููุท ุงููู ุจุณุจุจ ุชุญููู ุฌููุงุช ูู
ุชูุฆ ู
ุตุงุฏุฑ |
|
|
|
95 |
|
00:08:42,000 --> 00:08:42,320 |
|
ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ |
|
|
|
96 |
|
00:08:42,320 --> 00:08:43,620 |
|
ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ |
|
|
|
97 |
|
00:08:43,620 --> 00:08:45,860 |
|
ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ |
|
|
|
98 |
|
00:08:45,860 --> 00:08:50,670 |
|
ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ู
ุตุงุฏุฑ ุจุชุคุฏู ุฅูู ุงูุด |
|
|
|
99 |
|
00:08:50,670 --> 00:08:57,930 |
|
ุนู
ููุฉ clonal amplification ูุฎููุฉ ู
ุงุดู ููุด ูุฃูู |
|
|
|
100 |
|
00:08:57,930 --> 00:09:04,150 |
|
ุงูุฌููุงุช ุงููู ุจุชุญุชูู ุนูู ุชูุฑุน ูุงุญุฏุฉ ู
ุงุดู ูู ุงููู |
|
|
|
101 |
|
00:09:04,150 --> 00:09:08,110 |
|
ุนู
ูุช clonal amplification carcinogen ู
ุฑุฉ ุชุงููุฉ |
|
|
|
102 |
|
00:09:08,110 --> 00:09:14,550 |
|
ุจูุคุฏู ุฅูู mutation ู
ุงุดู of genes ูุจุงูุชุงูู ูุฐู |
|
|
|
103 |
|
00:09:14,550 --> 00:09:19,170 |
|
ุงูุฌููุงุช ุงูุชู ุชุญู
ู ุจูุง ุจูุงุณุทุฉ ุฎูุงูุง ู
ุนููุฉ ุชุฏูู |
|
|
|
104 |
|
00:09:19,170 --> 00:09:22,870 |
|
ูููููุฉ ุงู amplification of the single cell |
|
|
|
105 |
|
00:09:22,870 --> 00:09:28,450 |
|
ุงูู
ุชุญุณุณุฉ ููู
ููุชูุดู tumor antigen are well |
|
|
|
106 |
|
00:09:28,450 --> 00:09:33,330 |
|
demonstrated by viruses ูู
ุงู ุจุนุถ ุงูููุฑูุณุงุช virus |
|
|
|
107 |
|
00:09:33,330 --> 00:09:39,570 |
|
induced tumor ุจูุณู
ููู
oncogenic viruses ููุฐู ุจุชุคุฏู |
|
|
|
108 |
|
00:09:39,570 --> 00:09:44,910 |
|
ุฅูู ุทุจุนุง ุฃุธูุฑุช cross reactivity among tumors |
|
|
|
109 |
|
00:09:44,910 --> 00:09:54,010 |
|
induced by the same viruses ุงูุฌุฏูู ุงูุชุงูู ุจูุจูู ููุง |
|
|
|
110 |
|
00:09:54,010 --> 00:09:59,440 |
|
ุฃููุงุน tumor antigen ุฒู ู
ุง ุฃูุชู
ุดุงูููู ูู embryonic |
|
|
|
111 |
|
00:09:59,440 --> 00:10:04,000 |
|
ูููุง ุชุธูุฑ ุงูู oncofetal antigen ุฒู ุงู melanoma |
|
|
|
112 |
|
00:10:04,000 --> 00:10:11,960 |
|
associated gene ุงููู ูู ุฑูู
ูุงุญุฏ ูุงุชููู ุฒู ุงู |
|
|
|
113 |
|
00:10:11,960 --> 00:10:14,820 |
|
carcinogenic embryonic antigen ุฒู ุงู alpha |
|
|
|
114 |
|
00:10:14,820 --> 00:10:20,730 |
|
-fetoprotein ูููุง ุนุจุงุฑุฉ ุนู ุงููู ูู ุงูุชูุฌูุงุช ุจุชุธูุฑ |
|
|
|
115 |
|
00:10:20,730 --> 00:10:25,290 |
|
ุนูู overexpressed ุงูู
ูุฑูุถ ุฃููุง ุจุชุธูุฑ ุนูู ุงู |
|
|
|
116 |
|
00:10:25,290 --> 00:10:27,930 |
|
embryonic life ููููุง ุจุชุธูุฑ ุนูู ุงู tumor cell |
|
|
|
117 |
|
00:10:27,930 --> 00:10:35,270 |
|
differentiation ุฒู prostate specific antigen ู |
|
|
|
118 |
|
00:10:35,270 --> 00:10:41,830 |
|
ุงูุชูุฑูููุฒูู ู ุงู human epidermal growth factor |
|
|
|
119 |
|
00:10:41,830 --> 00:10:47,710 |
|
ู
ุงุดู ูููุฌุฏ antigenุงุช ุฒู ุงู always ููุงู ุงูู |
|
|
|
120 |
|
00:10:47,710 --> 00:10:50,290 |
|
Clonal Amplification ูููุงู ุงูู Point Mutationุ |
|
|
|
121 |
|
00:10:50,290 --> 00:10:54,550 |
|
ุชุฑูุฒูุง ูููู
ูุงุญุฏ ูุงุญุฏ Normal Cellular Gene |
|
|
|
122 |
|
00:10:54,550 --> 00:11:00,290 |
|
Products Expressed During Embryogenesis ูุฐุง ุฃูู |
|
|
|
123 |
|
00:11:00,290 --> 00:11:03,710 |
|
ูุงุญุฏ ุงููู ูููุง ุงููู ูู ุงูู Oncofetal Antigen ุฒู |
|
|
|
124 |
|
00:11:03,710 --> 00:11:06,830 |
|
ุงูู Melanoma Associated Antigen |
|
|
|
125 |
|
00:11:10,100 --> 00:11:15,100 |
|
ูุทุจุนุง ูุฐู ุนุจุงุฑุฉ ุนู ุงูุชูุฌูุงุช ู
ู
ูู ูุดุชุบููุง ูุณุชุฎุฏู
ูุง |
|
|
|
126 |
|
00:11:15,100 --> 00:11:19,820 |
|
ู vaccine ูุฃูู their expression is shared ูุนูู |
|
|
|
127 |
|
00:11:19,820 --> 00:11:28,060 |
|
ุจุชุดุชุฑู ูู ุงูู
ููุงููู
ุฉ ุจูุฌูุฏ ูุฐู ุงูุงูุชูุฌููุงุช ูุงุญูุง |
|
|
|
128 |
|
00:11:28,060 --> 00:11:31,920 |
|
ุนุดุงู ูุดุชุบู ุฌูุงุฒ ุงูู
ูุงุนุฉ ู
ู
ูู ูุงุฎุฏูุง ูุทุจุนุง ูุญูููุง |
|
|
|
129 |
|
00:11:31,920 --> 00:11:37,720 |
|
ูุงูุชูุฌููุงุช ุจุงูุชุงูู ุจุนุฏ ุทุจุนุง ู
ุง ูุนู
ููุง |
|
|
|
130 |
|
00:11:38,900 --> 00:11:43,320 |
|
Inactivation ูุจุงูุชุงูู ุจูุดุฑ ุฌูุงุฒ ุงูู
ูุงุนุฉ ู
ู ุฎูุงูู |
|
|
|
131 |
|
00:11:43,320 --> 00:11:48,860 |
|
Carcinoembryonic antigen CEA ุทุจุนุง |
|
|
|
132 |
|
00:11:48,860 --> 00:11:54,420 |
|
ูุฌุฏูู ูุนูู ูุฐุง ุนุจุงุฑุฉ ุนู protein ุบุงูุจุง found in |
|
|
|
133 |
|
00:11:54,420 --> 00:12:00,800 |
|
serum of patients with cancer of GIT ุฒู ุงู colon |
|
|
|
134 |
|
00:12:00,800 --> 00:12:10,650 |
|
cancer ูุฒูุงุฏุฉ ุงู level of CEA ูุฌุฏููุง ูู ุงูุฃู
ุฑุงุถ |
|
|
|
135 |
|
00:12:10,650 --> 00:12:14,630 |
|
ุฃุฎุฑู ุบูุฑ ุงููู ูู ุงู colon cancer ุงููู ูู non |
|
|
|
136 |
|
00:12:14,630 --> 00:12:18,970 |
|
specific or non-neoplastic diseases ุฒู ุงู |
|
|
|
137 |
|
00:12:18,970 --> 00:12:24,190 |
|
ulcerative colitis ู ุงู pancreatitis ุงููุงุณ ุฏููุฉ |
|
|
|
138 |
|
00:12:24,190 --> 00:12:29,750 |
|
they don't have cancer ูุจุงูุชุงูู this test is non |
|
|
|
139 |
|
00:12:29,750 --> 00:12:36,000 |
|
specific ุฃููุง ููุชู ุจุฑูุชูู ูุฐุง normally present at |
|
|
|
140 |
|
00:12:36,000 --> 00:12:40,580 |
|
high concentration ูู ุงูู fetal maternal serum ู |
|
|
|
141 |
|
00:12:40,580 --> 00:12:47,220 |
|
it's absent ูู ุงู normal adult individual ูููู |
|
|
|
142 |
|
00:12:47,220 --> 00:12:53,340 |
|
ู
ูุฌูุฏ ูู ุงููุงุณ ุงููู ุนูุฏูู
hepatoma and testicular |
|
|
|
143 |
|
00:12:53,340 --> 00:12:56,340 |
|
teratocarcinoma |
|
|
|
144 |
|
00:12:59,290 --> 00:13:04,150 |
|
ุงูุซุงูู ูู ุงูู Mutant Cellular Gene Product ูุงุชุฌ ุนู |
|
|
|
145 |
|
00:13:04,150 --> 00:13:09,370 |
|
ู
ููุชูุดู ุฌูู ุตุงุฑ ูู ู
ููุชูุดู ููู ุฃู
ุซูุฉ ูุซูุฑุฉ ุนูู ุฐูู |
|
|
|
146 |
|
00:13:09,370 --> 00:13:15,110 |
|
ู
ููุง ูู ุงููCML ุงูุชุงูุฑูุณูู ูุงูููุฒ activity ุจุชุฒูุฏ |
|
|
|
147 |
|
00:13:15,110 --> 00:13:20,510 |
|
ูุจุงูุชุงูู ุจูุตูุฑ ููู ุงููู ูู uncontrolled cellular |
|
|
|
148 |
|
00:13:20,510 --> 00:13:25,650 |
|
proliferation ููู ุงุณุชุฎุฏู
ูุง inhibitor ููุฌูู ุชุจุน ุงู |
|
|
|
149 |
|
00:13:25,650 --> 00:13:33,490 |
|
PCR APL ุงูุฌูู ุงููุงูู
ุฑููู ุงููู ุจูุชููู ูู ุงููCML ุฃู |
|
|
|
150 |
|
00:13:33,490 --> 00:13:39,150 |
|
ู
ุง ูุณู
ู ุจุงููููุงุฏููููุง ูุฑูู
ูุณูู
ุงุชุดูู |
|
|
|
151 |
|
00:13:39,150 --> 00:13:43,270 |
|
ุฃู promise for inducing a complete hematological |
|
|
|
152 |
|
00:13:43,270 --> 00:13:49,150 |
|
response ูู ูู ูุฌุงุญ ุชู
ุจุงุณุชุฎุฏุงู
ุงููinhibitor ูู |
|
|
|
153 |
|
00:13:49,150 --> 00:13:57,770 |
|
ุนู
ููุฉ ูุจุญ ุฌู
ุงุญ ุงููู ูู ุงููCML disease ุทุจุนุง ูุงูููู
|
|
|
|
154 |
|
00:13:57,770 --> 00:14:03,750 |
|
ุจูุนุชุจุฑููุง targeting therapy ุงูููู
ูุนูู ุฃุธูุฑ ูุฌุงุญุงุช |
|
|
|
155 |
|
00:14:03,750 --> 00:14:08,910 |
|
ูุซูุฑุฉ ูู
ุฑุถู ุณูุฃู
ุงู ุงุณุชุบููุง ุบุงูุจุง ุนู ุงู |
|
|
|
156 |
|
00:14:08,910 --> 00:14:13,930 |
|
chemotherapy ุงูู
ุซุงู |
|
|
|
157 |
|
00:14:13,930 --> 00:14:19,610 |
|
ุงูุขุฎุฑ ุนู mutant cellular gene ูู ุงู mutation ุงููู |
|
|
|
158 |
|
00:14:19,610 --> 00:14:25,050 |
|
ุจุชุตูุฑ ูู ุงู P53 protein ุทุจุนุง ุงู P53 mutation |
|
|
|
159 |
|
00:14:29,510 --> 00:14:35,210 |
|
ุจุชุธูุฑ ุจุชุธูุฑ ุงู it changes in p53 ูุนูู ุงููุชูุฌุฉ |
|
|
|
160 |
|
00:14:35,210 --> 00:14:42,770 |
|
changes in p53 ู ุงู protein ุงููู ุจูุชููู ุบุงูุจุง |
|
|
|
161 |
|
00:14:42,770 --> 00:14:47,170 |
|
ุจูุดุชุบู as a suppressor of cellular growth ูุฐุง ูู |
|
|
|
162 |
|
00:14:47,170 --> 00:14:55,510 |
|
ุงููุถุน ุงูุทุจูุนู ุงู ุงู P53 code for protein ุจูุนู
ู |
|
|
|
163 |
|
00:14:55,510 --> 00:15:03,870 |
|
stopping ููู cell cycle at certain stage |
|
|
|
164 |
|
00:15:03,870 --> 00:15:08,650 |
|
ููู
ูุตูุฑ ููู ุฎูู ุจูููู ููู
ูุตูุฑ ููู ู
ููุชูุดู ุจูุทูุน |
|
|
|
165 |
|
00:15:08,650 --> 00:15:12,730 |
|
ููุง ุจุฑูุชูู ุฃุตูุง ููู ู
ููุชูุดู ุงููู ู
ู
ูู ูุนู
ู ูุดุชุบู |
|
|
|
166 |
|
00:15:12,730 --> 00:15:20,670 |
|
ุงูุณุจุฑุณ ูุงูุณููุฌุฑุงุซ tumor immunity in vivo can be |
|
|
|
167 |
|
00:15:20,670 --> 00:15:25,710 |
|
induced by vaccination against mutant p53 peptide |
|
|
|
168 |
|
00:15:25,710 --> 00:15:35,450 |
|
ูู ุฃุนุทูุง ุงู p53 peptide ู
ุน ุงู IL-12 ุจูุนุชุจุฑ ูุฐุง ู |
|
|
|
169 |
|
00:15:35,450 --> 00:15:36,190 |
|
vaccine |
|
|
|
170 |
|
00:15:39,970 --> 00:15:43,250 |
|
ููุฌุฏูุง ุงู ุงูู T lymphocyte directed against normal |
|
|
|
171 |
|
00:15:43,250 --> 00:15:47,090 |
|
p53 might preferentially destroy a tumor cell ุทุจุนุง |
|
|
|
172 |
|
00:15:47,090 --> 00:15:49,970 |
|
ูุฐุง ุงูููุงู
ุจูุดูุฏ ุงู T lymphocyte ูT lymphocyte |
|
|
|
173 |
|
00:15:49,970 --> 00:15:53,610 |
|
ุจุชูุงุฌู
ุงู tumor cell ูู ุจุงูุชุงูู ู
ู
ูู ูุณุชุฎุฏู
ู |
|
|
|
174 |
|
00:15:53,610 --> 00:16:01,770 |
|
vaccine ูู ู IL-12 ู
ุน ุจุนุถ ู
ู ุญููู ู
ุน ุจุนุถ ุชูุงุชุฉ |
|
|
|
175 |
|
00:16:01,770 --> 00:16:05,310 |
|
tumor antigen encoded by oncogene ุทุจุนุง ูููุง ุจูุนุฑู |
|
|
|
176 |
|
00:16:05,310 --> 00:16:08,830 |
|
ุงู ุงู oncogene ูู ุนุจุงุฑุฉ ุนู |
|
|
|
177 |
|
00:16:13,680 --> 00:16:19,240 |
|
ูุจุงูุชุงูู ุฌุงู ุจุนุฏ ู
ุง ุตุงุฑ ููู mutation ูู ุงู normal |
|
|
|
178 |
|
00:16:19,240 --> 00:16:23,020 |
|
gene ู ุงู normal gene ุจูุณู
ูู proto-oncogene ุงููู |
|
|
|
179 |
|
00:16:23,020 --> 00:16:28,160 |
|
ููู
ู
ุง ูุชุญูู ู proto-oncogene ูู C-oncogen |
|
|
|
180 |
|
00:16:30,930 --> 00:16:35,950 |
|
ุจูุชููู ุงููู ูู as a mutation ุทุจุนุง as a result of |
|
|
|
181 |
|
00:16:35,950 --> 00:16:42,990 |
|
mutation ุจูุตูุฑ ููู ุงููู ูู tumor ูุทุจุนุง ููู ุณุฌูุฉ |
|
|
|
182 |
|
00:16:42,990 --> 00:16:48,050 |
|
ุญุงูุงุช ูุซูุฑุฉ ู
ู ุฎูุงู ุนูุงูุฉ ุงู tumor ุงู ุงู viruses |
|
|
|
183 |
|
00:16:48,050 --> 00:16:51,890 |
|
ุจุงูุฃุด ุจุงู |
|
|
|
184 |
|
00:16:55,500 --> 00:17:02,580 |
|
ุฃู ูุฏุง ูู ูุธุฑูุฉ ุงูุงูููุฌูู ุชูุชุฑุญ ุฃู postulate that |
|
|
|
185 |
|
00:17:02,580 --> 00:17:06,780 |
|
such proto-oncogene ููู
ุจุณูู mutation or activation |
|
|
|
186 |
|
00:17:06,780 --> 00:17:10,300 |
|
display increased expression or inappropriate |
|
|
|
187 |
|
00:17:10,300 --> 00:17:14,440 |
|
expression ุจุณูู increased ุงู inappropriate |
|
|
|
188 |
|
00:17:14,440 --> 00:17:18,500 |
|
expression ููู mutated form of their gene a |
|
|
|
189 |
|
00:17:18,500 --> 00:17:22,480 |
|
product ูุจุงูุชุงูู ุจูุณุงูู
ูุซูุฑ ูู ุชุญููู ุงูุฎูุงูุง |
|
|
|
190 |
|
00:17:22,480 --> 00:17:28,100 |
|
ุงูุทุจูุนูุฉ ุงูู ุฎูุงูุง ุณุฑุทุงููุฉ ูุงููู ุจูุชููู cancer |
|
|
|
191 |
|
00:17:28,100 --> 00:17:31,680 |
|
ุทุจุนุง ุนู
ููุฉ ุงู mutation ุจุชุชู
ู
ู ุฎูุงู ุงู chromosomal |
|
|
|
192 |
|
00:17:31,680 --> 00:17:34,640 |
|
translocation point mutation gene amplification |
|
|
|
193 |
|
00:17:34,640 --> 00:17:43,250 |
|
ูููุฐุง ููุฐู ุญุงูุงุช ูุซูุฑุฉ ู
ุงุดู ุตุงุฑ ูููุง activation ูู |
|
|
|
194 |
|
00:17:43,250 --> 00:17:48,130 |
|
cellular proto-oncogene in a human ุฃู CMEC ุตุงุฑ ูู |
|
|
|
195 |
|
00:17:48,130 --> 00:17:56,170 |
|
Genetic Rearrangement ูุชุบูุฑุช ุตุงุฑ ููู |
|
|
|
196 |
|
00:17:56,170 --> 00:17:59,410 |
|
Translocation ู
ุง ุจูู ูุฑูู
ูุณูู
ุงุช ุชู
ุงููุฉ ูุฃุฑุจุน ุนุดุฑุฉ ุฃู |
|
|
|
197 |
|
00:17:59,410 --> 00:18:02,190 |
|
ุซู
ุงููุฉ ูุงุซููู ุฃู ุซู
ุงููุฉ ูุงุซููู ูุนุดุฑูู ูุนู
ููุง |
|
|
|
198 |
|
00:18:02,190 --> 00:18:08,860 |
|
ุญุงุฌุฉ ุจูุณู
ููุง Perkins lymphoma APL ุฃูุถูุง ุตุฑูู |
|
|
|
199 |
|
00:18:08,860 --> 00:18:12,920 |
|
Genetic Transformation ุฃู Rearrangement ู
ู ุฎูุงู |
|
|
|
200 |
|
00:18:12,920 --> 00:18:17,940 |
|
Translocation ู
ุง ุจูู ูุฑูู
ูุณูู
9 ู22 ูุนู
ู CML ููุฐุง |
|
|
|
201 |
|
00:18:17,940 --> 00:18:24,800 |
|
CH ุฑุฃุณ CK ุฑุฃุณ ู
ุฌู
ูุนุฉ ุงูุฑุฃุณ ูุงูุฃูู
ู ุจุฑุถู ูููู
|
|
|
|
202 |
|
00:18:24,800 --> 00:18:30,000 |
|
ุจูููููุง different types of tumor ู
ุซููุง |
|
|
|
203 |
|
00:18:30,000 --> 00:18:35,080 |
|
ุงูุจุฑูุชูุงูููุฌูู ูุฐู ูู ููู
ู
ุง ุตุงุฑ ูู activation ูู C |
|
|
|
204 |
|
00:18:35,080 --> 00:18:43,020 |
|
-Myc C-A-B-L C-K ููุฑูุฒ ุงู
ุชุฒูุณุช ุฌููุฒ are associated |
|
|
|
205 |
|
00:18:43,020 --> 00:18:47,680 |
|
with Perkins lymphoma ุณููู
ุงูุงููุงูููู ุงูุฑููููู |
|
|
|
206 |
|
00:18:47,680 --> 00:18:55,700 |
|
ูุงุฑุณูููู
ุง ุจุงูุชุฑุชูุจ ุงูุฏุฑุงุณุงุช ุนูู ุงูุญููุงู ุฃูุถูุง ุฃุธูุฑุช |
|
|
|
207 |
|
00:18:55,700 --> 00:19:04,150 |
|
ุฃู ุฃู ูู ุนูุงูุฉ ู
ุจุงุดุฑุฉ ู
ุง ุจูู ุงูุงูููุฌูููู ููุฑูุณ ูู
ุง |
|
|
|
208 |
|
00:19:04,150 --> 00:19:11,090 |
|
ุจูู cross reactivity ูุทุจุนุง ุฃู
ุฑ ุทุจูุนู ุฌุฏุง ูุฃู ุงู |
|
|
|
209 |
|
00:19:11,090 --> 00:19:17,710 |
|
virus ุงูุงูููุฌูููู ููุฑูุณ ูุนูู ุจูุนู
ู expression of |
|
|
|
210 |
|
00:19:17,710 --> 00:19:24,190 |
|
ุงู antigenุงุชู ุนูู ุงู tumor cell ุจุบุถ ุงููุธุฑ ุนูู ู
ููุน |
|
|
|
211 |
|
00:19:24,190 --> 00:19:28,830 |
|
ุงูุฎูุงูุง ุงููู ุตุงุฑ ุงููู ููุง tumor ุฃู ููุน ุงู animal |
|
|
|
212 |
|
00:19:28,830 --> 00:19:35,240 |
|
species ูุฒู ู
ุง ูููุง ููู
ูู ุฏูุงุฆู ุฃู ูู ุณุฌูุฉ ุญุงูุงุช |
|
|
|
213 |
|
00:19:35,240 --> 00:19:41,600 |
|
ูุซูุฑุฉ ู
ุซุจุชุฉ ุนูู ุนูุงูุฉ ุงููู ูู ุงู viruses ุจุงู tumor |
|
|
|
214 |
|
00:19:41,600 --> 00:19:47,200 |
|
ุฒู ุงู Epstein-Barr Virus ุจูุนู
ู ุงููู ูู ุงู human |
|
|
|
215 |
|
00:19:47,200 --> 00:19:51,520 |
|
T cell leukemia virus ู ุงู human papilloma virus |
|
|
|
216 |
|
00:19:51,520 --> 00:19:54,820 |
|
ุงูุฃููุงูู ุจูุนู
ู Perkins ูุงูุซุงูู ุจูุนู
ู leukemia |
|
|
|
217 |
|
00:19:54,820 --> 00:19:57,840 |
|
ูุงูุซุงูุซ ุจูุนู
ู cervical tumor |
|
|
|
218 |
|
00:20:01,280 --> 00:20:06,980 |
|
ู
ุง ูู ุงูุนูุงู
ู ุงูุชู ุชุคุซุฑ ูู ุงู incidence of cancer |
|
|
|
219 |
|
00:20:06,980 --> 00:20:15,520 |
|
ูุงููุง ูู ู
ุตุทูุญ ุงุณู
ู ุงู immune ุงู immune |
|
|
|
220 |
|
00:20:15,520 --> 00:20:20,270 |
|
surveillance ูุงูู
ุตุทูุญ ูุฐุง ูุนูู ุฅูู ููู |
|
|
|
221 |
|
00:20:20,270 --> 00:20:22,990 |
|
immunological resistance against the development |
|
|
|
222 |
|
00:20:22,990 --> 00:20:32,150 |
|
of cancer ุงูุฌุณู
ูุชุตุฏู ุฅูู ุงู tumor ู
ู ุฎูุงู ุฌูุงุฒ |
|
|
|
223 |
|
00:20:32,150 --> 00:20:37,490 |
|
ุงูู
ุงูุนุฉ ูู
ู ุงููุงุณ ุงููู ู
ุง ุนูุฏูู
ุด ู
ุงูุนุฉ ุนูุฏูู
|
|
|
|
224 |
|
00:20:37,490 --> 00:20:40,590 |
|
immunodeficiency disease usually are susceptible |
|
|
|
225 |
|
00:20:40,590 --> 00:20:45,070 |
|
to viral infection and certain malignant neoplasm |
|
|
|
226 |
|
00:20:52,140 --> 00:20:59,480 |
|
ุทุจุนุง ุงู tumor cell ุงููู ุจุชุชููู ุฎูุงู virus are |
|
|
|
227 |
|
00:20:59,480 --> 00:21:04,420 |
|
sensitive to immunologic destruction ูู
ุน ุฐูู ุงู |
|
|
|
228 |
|
00:21:04,420 --> 00:21:07,400 |
|
natural development of immunological response |
|
|
|
229 |
|
00:21:07,400 --> 00:21:10,600 |
|
usually fail to prevent cancer from developing |
|
|
|
230 |
|
00:21:10,600 --> 00:21:16,060 |
|
ูุนูู ุตุญูุญ ุฌูุงุฒ ุงูู
ูุงุนุฉ ุจูุดุชุบู ููู ูู
ุน ุฐูู ุงูุณุฑุทุงู |
|
|
|
231 |
|
00:21:16,060 --> 00:21:25,020 |
|
ุฃู ุงู tumor cell ุจุชูุฌุญ ููู ูู ุฅููุง ุชูู
ู ูุชุชุทูุฑ ูุนูู |
|
|
|
232 |
|
00:21:25,020 --> 00:21:31,320 |
|
ุจูุฃู
ู ูู ุงูู
ุณุชูุจู ุฃู ูููู ููู good |
|
|
|
233 |
|
00:21:31,320 --> 00:21:36,720 |
|
response example by vaccination with tumor antigen |
|
|
|
234 |
|
00:21:36,720 --> 00:21:41,280 |
|
that will serve as viable option for prevention or |
|
|
|
235 |
|
00:21:41,280 --> 00:21:47,490 |
|
treatment of cancer in the future Effect of |
|
|
|
236 |
|
00:21:47,490 --> 00:21:50,770 |
|
Mechanism in Tumor Immunology ู
ุง ูู ุงูู
ููุงููุฒู
ุงุช |
|
|
|
237 |
|
00:21:50,770 --> 00:21:55,690 |
|
ูุฌุฏูุง ุฃูู both Adaptive ู Innate Immune Response |
|
|
|
238 |
|
00:21:55,690 --> 00:22:01,970 |
|
ุจููุนุจูุง ุฏูุฑ ูุจูุฑ ููู ุงูุนูุงูุฉ ู
ุง ุจูู ุงู host ู ุงู |
|
|
|
239 |
|
00:22:01,970 --> 00:22:08,290 |
|
tumor Immune Effect of Mechanism ูุฌุฏุช ูุฌุฏููุง ุงู it |
|
|
|
240 |
|
00:22:08,290 --> 00:22:13,760 |
|
can destroy tumor cell in vitro ุจุงูุชุฌุฑุจุฉ ุชุชู
ุซู ูู |
|
|
|
241 |
|
00:22:13,760 --> 00:22:18,280 |
|
ุงูู Antibody ูู ุงูู B-cellุ ุงูู NK-cellุ ุงูู Lact |
|
|
|
242 |
|
00:22:18,280 --> 00:22:22,240 |
|
-cellุ ุงูู Macrophageุ ุงูู Cytokine ูููุง ุฃุจุงุฑุน ุนู |
|
|
|
243 |
|
00:22:22,240 --> 00:22:27,660 |
|
ู
ููุงููุฒู
ุงุช ุฃุซุจุชุช in vitro ุจุฅููุง ุจุชุฏู
ุฑ ุงูุฎูุงูุง |
|
|
|
244 |
|
00:22:27,660 --> 00:22:33,860 |
|
ุงูุณุฑุทุงููุฉ ููู ุงูู Antibody ู ุงูู B-cell ุนูู ุณุจูู |
|
|
|
245 |
|
00:22:33,860 --> 00:22:36,820 |
|
ุงูู
ุซุงู ูู ูุฌูุฏ ููู
ุจููู
ูุช ุจุชููู Antibody ูู ูุฌูุฏ |
|
|
|
246 |
|
00:22:36,820 --> 00:22:43,040 |
|
ููู
ุจููู
ูุช ู
ูุชุฌุงุช ุฃู Opsonization ุงูุขู ู
ููุงููุฒู
ู
ูููู
|
|
|
|
247 |
|
00:22:43,040 --> 00:22:46,980 |
|
ุจุดูู ูุงู
ู ุชุณู |
|
|
|
248 |
|
00:22:46,980 --> 00:22:49,460 |
|
ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
|
249 |
|
00:22:49,460 --> 00:22:53,260 |
|
ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
|
250 |
|
00:22:53,260 --> 00:22:58,100 |
|
ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
|
251 |
|
00:22:58,100 --> 00:23:01,720 |
|
ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู ุชุณู |
|
|
|
252 |
|
00:23:01,720 --> 00:23:05,360 |
|
ุชุณู |
|
|
|
253 |
|
00:23:07,310 --> 00:23:14,930 |
|
ููุฌุฏููุง ูุซูุฑุฉ ูููุฉ ุนูู ุงูุฎูุงูุง ุงูู dispersed ุงููู |
|
|
|
254 |
|
00:23:14,930 --> 00:23:21,030 |
|
ูู ุงูู
ููุตูุฉ ุนูู ุงู cell suspension ููุฌุฏูุง ูุนุงููุชูุง |
|
|
|
255 |
|
00:23:21,030 --> 00:23:26,890 |
|
ุฃูุซุฑ ุจูุซูุฑ ุนูู ูุฐู ุงูุฎูุงูุง ุงูู
ููุตูุฉ ุฃูุซุฑ ู
ู ุงู |
|
|
|
256 |
|
00:23:26,890 --> 00:23:31,250 |
|
solid tumor ุงููู ูู ุจูููู ู
ุชู
ุงุณู ููุดุ ูุฃู ุฌูุงุฒ |
|
|
|
257 |
|
00:23:31,250 --> 00:23:33,850 |
|
ุงูู
ูุงุนุฉ ูุณุชุทูุน ุฃู ูุตู ุฅูู ูุฐู ุงูุฎูุงูุง |
|
|
|
258 |
|
00:23:37,530 --> 00:23:43,770 |
|
ู
ู ุงูู Solid Tumour Cells ูุดูู ุฃูู ู
ููุงููุฒู
ุงููู |
|
|
|
259 |
|
00:23:43,770 --> 00:23:49,890 |
|
ูู PCR Response ูู Tumour ูุฌุฏูุง ุฃู IgPo, IgM ู IgG |
|
|
|
260 |
|
00:23:49,890 --> 00:23:55,690 |
|
Antibody ูุฌุฏููุง in vitro can kill or destroy the |
|
|
|
261 |
|
00:23:55,690 --> 00:24:00,450 |
|
tumour cell ุทุจุนุง ูู ูุฌูุฏ ุงู complement ุทุจุนุง ูุฐุง |
|
|
|
262 |
|
00:24:00,450 --> 00:24:07,370 |
|
ุงูููุงู
ุฃุซุจุชูุงู ุจุงูุชุฌุฑุจุฉ in vitroุ ุงูุฏุฑุงุณุงุช ุนูู |
|
|
|
263 |
|
00:24:07,370 --> 00:24:15,830 |
|
ุงูู
ุงูุณ ุฃูุถุง ุฃุซุจุชุช Indicate ุจุชุคุดุฑ ุฃู ุจุชุฏู ุนูู ุฃู ุงู |
|
|
|
264 |
|
00:24:15,830 --> 00:24:19,350 |
|
Antitumor Antibody are effective in destroying |
|
|
|
265 |
|
00:24:19,350 --> 00:24:25,250 |
|
some leukemia and lymphoma ูุทุจุนุง ุจุชููู ู
ู ุงู |
|
|
|
266 |
|
00:24:25,250 --> 00:24:31,710 |
|
metastasis in several other tumors systemุ ุชูุณูุด |
|
|
|
267 |
|
00:24:31,710 --> 00:24:37,780 |
|
ุฃู ุงุญูุง ููุญูู ุนูู ุชุฌุงุฑุจ ุญุฏุซุช in vitro ูููุณ in vivo |
|
|
|
268 |
|
00:24:37,780 --> 00:24:43,860 |
|
ุขุฎุฑ ุญุฏุซ ุทุจุนุง ุฃุซุจุชุช ุฃู ูุฐู ุงูุงูุชูุจุงุฏู ูุง ุชุฃุซูุฑ ููุง |
|
|
|
269 |
|
00:24:43,860 --> 00:24:50,500 |
|
ููุง ุจุชูุชู ุฎูุงูุง ุณุฑุทุงููุฉ ู
ุงุดู ุฅุฐุง ูุงู ุงู tumor in |
|
|
|
270 |
|
00:24:50,500 --> 00:24:55,820 |
|
solid form ููู
ู
ุง ูููู ุงู tumor in solid formุ ุจููุงุฒ |
|
|
|
271 |
|
00:24:55,820 --> 00:24:58,760 |
|
ุซุงูู destruction of tumor cell by opsonization of |
|
|
|
272 |
|
00:24:58,760 --> 00:25:02,320 |
|
phagocytosis ูููุง ุจูุนุฑู ุฃูู ุงูุฎููุฉ ุงูุบุฑูุจุฉ ุจูู |
|
|
|
273 |
|
00:25:02,320 --> 00:25:05,960 |
|
ุชููู ููุง antibody ู ุจูุนุฏ ุนูู ุณุทุญ ุงูุฎูุงูุง ู
ุฑุงุช ู |
|
|
|
274 |
|
00:25:05,960 --> 00:25:11,240 |
|
ุจูุตูุฑ ููู ู ุจูุนู
ู opsonization ููุฐู ุงูุฎููุฉ ุทุจุนุง |
|
|
|
275 |
|
00:25:11,240 --> 00:25:15,240 |
|
ุชุชุนุฑู ุนูููุง ุงู phagocytic cell ู ุจุชุฎูุตูุง ู
ููุงุ In |
|
|
|
276 |
|
00:25:15,240 --> 00:25:23,980 |
|
vitro destruction of tumor cell ุจูุงุณุทุฉ Trigocytic |
|
|
|
277 |
|
00:25:23,980 --> 00:25:28,780 |
|
cell ุฃุตูุง ูุชู |
|
|
|
278 |
|
00:25:28,780 --> 00:25:32,900 |
|
ุฃู ุนู
ู destruction ูู tumor cell ูู ูุฌูุฏ ุงู ant |
|
|
|
279 |
|
00:25:32,900 --> 00:25:39,360 |
|
tumor ุงููู ูู immune serum and complementุ ู
ููุงููุฒู
|
|
|
|
280 |
|
00:25:39,360 --> 00:25:43,220 |
|
ุซุงูุซ Antibody-mediated loss of adhesion properties |
|
|
|
281 |
|
00:25:43,220 --> 00:25:52,080 |
|
of tumor cellุ ุงูู Adhesion Molecule ูุงุฒู
ุชุชุญูู |
|
|
|
282 |
|
00:25:52,080 --> 00:25:56,540 |
|
ุนุดุงู ูุตูุฑ ููู ู
ุชุงุณุชุงุณูุณ |
|
|
|
283 |
|
00:25:56,540 --> 00:26:01,300 |
|
ู
ุชุงุณุชุงุณูุณ ุงูุชููุฉ ู
ุฎุชููุฉ ุนู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู |
|
|
|
284 |
|
00:26:01,300 --> 00:26:06,240 |
|
ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู ู
ุฎููู |
|
|
|
285 |
|
00:26:10,100 --> 00:26:15,140 |
|
ุนุดุงู ุชุฑุชุจุท ุจุฎูุงูุง ุฃู ุจุงูุณุฌุฉ ุฃุฎุฑู ู
ูุฌูุฏุฉ ูู ุฃู
ุงูู |
|
|
|
286 |
|
00:26:15,140 --> 00:26:19,300 |
|
ุฃุฎุฑู ูุจุงูุชุงูู ุจูุญุตู ููู metastasisุ ุงู antibody |
|
|
|
287 |
|
00:26:19,300 --> 00:26:24,220 |
|
ุงูู
ูุฌูุฉ ุถุฏ ูุฐู ุงูู tumor cell surfaces can |
|
|
|
288 |
|
00:26:24,220 --> 00:26:28,080 |
|
interfere with the adhesive properties ููุฐุง ุงูููุงู
|
|
|
|
289 |
|
00:26:28,080 --> 00:26:33,200 |
|
ุฃูุถุง done in vitro cell mediated responses |
|
|
|
290 |
|
00:26:33,200 --> 00:26:38,100 |
|
destruction by cytotoxic T lymphocytes ุฃูุถุง |
|
|
|
291 |
|
00:26:38,100 --> 00:26:44,150 |
|
ุฃุซุจุชูุงูุง in vitroุ ูู ู
ุณุคููุฉ ุนู ูุฐู ุงูุฎูุงูุง ูู
ุณุคููุฉ |
|
|
|
292 |
|
00:26:44,150 --> 00:26:52,830 |
|
ุนู ุฅุฏุงุฑุฉ ุชู
ุฑ ุณู ุจูุฑูุง ูู ุงููุงูุนุ ุทุจุนุง ุงูู Antibody |
|
|
|
293 |
|
00:26:52,830 --> 00:26:55,890 |
|
Dependent Cell Mediated Cytotoxicity ุฏู ุนุจุงุฑุฉ ุนู |
|
|
|
294 |
|
00:26:55,890 --> 00:27:01,870 |
|
ู
ููุงููุฒู
ุจุชู
ู ุฎูุงู ุงุฑุชุจุงุท ุงู .. ุงู .. ุงู .. ุงู .. |
|
|
|
295 |
|
00:27:01,870 --> 00:27:06,090 |
|
Phagocytic Cell ุจุงู Fc Portion of Antibody ุงููู |
|
|
|
296 |
|
00:27:06,090 --> 00:27:09,670 |
|
ุฌุงูุณ ุนูู ุณุทุญ ุงูุฎููุฉ ุงูุณุฑุทุงููุฉุ ุจุงูุชุงูู ุจูุตูุฑ ูู |
|
|
|
297 |
|
00:27:09,670 --> 00:27:14,510 |
|
cell to cell contact ู ุจูุตูุฑ ูู releasing ู ุงู |
|
|
|
298 |
|
00:27:14,510 --> 00:27:20,050 |
|
substance which can kill the tumor cellุ ุงุณุชุฑูุดู of |
|
|
|
299 |
|
00:27:20,050 --> 00:27:31,790 |
|
tumors by NK or NKT or ูุฃูุณู ุงูุชูุงุชุฉ ู
ุงุดูุ ูุง ุนูุงูุฉ |
|
|
|
300 |
|
00:27:31,790 --> 00:27:35,650 |
|
ุทุจุนุง ููุง ุจูุนุฑู ุฃูู ุฎูุงุต ุฃู ุงูุงููุณู ุชุชุญุณุณ ุงููู ูู |
|
|
|
301 |
|
00:27:38,140 --> 00:27:42,000 |
|
ู
ููููููู ุนูู ุณุทุญ ุงูุฎูุงูุง ุชููู
ุฑ ุณูู ุบุงูุจุง ุชุนู
ู |
|
|
|
302 |
|
00:27:42,000 --> 00:27:46,620 |
|
shading ุชุนู
ู masking ู ุงููู ูู ุงู MSC ู
ููููููู |
|
|
|
303 |
|
00:27:46,620 --> 00:27:52,520 |
|
ูุจุงูุชุงูู ุชุชุนุฑู ุนูููุง ุงููู ูู ุงูุงููุณูุ ุฃูุถุง ุงูุงููุณู |
|
|
|
304 |
|
00:27:52,520 --> 00:27:56,960 |
|
have receptor ูู FC portion of IGG ูุจุงูุชุงูู ู
ู |
|
|
|
305 |
|
00:27:56,960 --> 00:28:04,500 |
|
ุฎูุงู ADCC ู
ู
ูู ุชุชุฎูุต ู
ู ุงู tumor cellุ ุจู
ุฌุฑุฏ ู
ุง |
|
|
|
306 |
|
00:28:04,500 --> 00:28:07,680 |
|
ุชุฑุชุจุท ุจุชูุฑุฒ ุงู tumor ูุฅู ูู cell tumor necrosis |
|
|
|
307 |
|
00:28:07,680 --> 00:28:13,120 |
|
factor ฮฑ ู ุงููู ุจูุนู
ููู
ูุฑุฌู tumor necrosis ุงู lag |
|
|
|
308 |
|
00:28:13,120 --> 00:28:18,820 |
|
ุฃูุถุง ูู ุนุจุงุฑุฉ ุนู tumor specific killer cells ู |
|
|
|
309 |
|
00:28:18,820 --> 00:28:22,660 |
|
ู
ู
ูู ูุณุชูุจุทูุง ุฃู ูุงุฎุฏูุง ู
ู ุจุนุถ ุงูู
ุฑุถู ุงููู ุนูุฏูู
|
|
|
|
310 |
|
00:28:22,660 --> 00:28:29,400 |
|
tumorุ ุจูู
ููุง ุจุฑุง ูู ูุฌูุฏ IL-2 ููุฑุฌุนูุง ุซุงูู ููู
ุฑูุถ |
|
|
|
311 |
|
00:28:29,400 --> 00:28:36,920 |
|
ููุณูุ ูุฏููุฉ ุจูุดุทู ุงููู ูู ุงูู mechanism ุงููู ุจูุญูู |
|
|
|
312 |
|
00:28:36,920 --> 00:28:40,580 |
|
ุนูู ุณูุงุก ูุงู ADCC ุงู Direct Killing By Ankyl Cell |
|
|
|
313 |
|
00:28:40,580 --> 00:28:43,600 |
|
Destruction |
|
|
|
314 |
|
00:28:43,600 --> 00:28:46,300 |
|
of tumor cell by activated macrophage and |
|
|
|
315 |
|
00:28:46,300 --> 00:28:50,800 |
|
neutrophilุ ุทุจุนุง ูููุง ุจูุนุฑู ุฃู ุงู macrophage ุจุชุชูุดุท |
|
|
|
316 |
|
00:28:51,320 --> 00:28:57,540 |
|
by releasing gamma interferonุ ุงูุชุดุชุช ู
ู ุฎูุงู TCD4 |
|
|
|
317 |
|
00:28:57,540 --> 00:29:08,620 |
|
lymphocytesุ ูุทุจุนุง ุงู gamma interferon ูู tumor |
|
|
|
318 |
|
00:29:08,620 --> 00:29:15,280 |
|
specificุ ุจูุณุชุฎุฏู
|
|
|
|
319 |
|
00:29:15,280 --> 00:29:16,480 |
|
ู cytotoxic |
|
|
|
320 |
|
00:29:20,430 --> 00:29:26,630 |
|
Cytokine against tumor cellุ ุฃูุถุง ุจุฅุทูุงู ูุงุฒูุฒุงูู
|
|
|
|
321 |
|
00:29:26,630 --> 00:29:30,730 |
|
ูููุฑูุณ ูุงูุชูุฑู ุงููุง ุจููุชููุง tumor cell |
|
|
|
322 |
|
00:29:35,370 --> 00:29:38,730 |
|
ุฃู
ุง ุชุนู
ู Inhibition ุฃู ุชุนู
ู Growth ููPremarignant |
|
|
|
323 |
|
00:29:38,730 --> 00:29:44,050 |
|
ูTumorignant Cellุ ุทุจุนุงู ูุนุฑู ุฃูู ููู Cytokine |
|
|
|
324 |
|
00:29:44,050 --> 00:29:47,650 |
|
Inhibitor ูCytokine ูููู Stimulatory Transformed |
|
|
|
325 |
|
00:29:47,650 --> 00:29:51,350 |
|
Growth Factor Betaุ ูุงุญุฏ ู
ู ุงููCytokine ุงููู ุจูุนู
ู |
|
|
|
326 |
|
00:29:51,350 --> 00:29:56,990 |
|
Inhibition ูู immune response ูุจุงูุชุงูู ุจูุตูุฑ ููู |
|
|
|
327 |
|
00:29:56,990 --> 00:30:04,460 |
|
promotion ูู tumor growth ูู ูุฐู ุงูุญุงูุฉ ู ุจูุงูู |
|
|
|
328 |
|
00:30:04,460 --> 00:30:08,980 |
|
ุงูุฌููุฌูููู ุจู
ุนูู |
|
|
|
329 |
|
00:30:08,980 --> 00:30:16,720 |
|
ุฃูู ุจูุณูู ูู ุนู
ููุฉ ูู
ู ุงููุงูุณุฑ ู
ู ุฎูุงู ุงููู ูู |
|
|
|
330 |
|
00:30:16,720 --> 00:30:23,120 |
|
ุชูููู ุงูุงูุฌููุฌูููุณู ุงููู ูู blood vessels to the |
|
|
|
331 |
|
00:30:23,120 --> 00:30:25,360 |
|
tumor cell |
|
|
|
332 |
|
00:30:27,510 --> 00:30:32,910 |
|
Tumor Microsfactory ู Interferon ุฌุนู
ุง ุฃูุถุง ููู
|
|
|
|
333 |
|
00:30:32,910 --> 00:30:37,770 |
|
Anti-Tumor Effect ููุดุ ูุฃููู
ุจูุนู
ููุง Upregulation |
|
|
|
334 |
|
00:30:37,770 --> 00:30:44,190 |
|
ูู MSC Class 1 ู2 ูุจุงูุชุงูู ุฌูุงุฒ ุงูู
ูุงุนุฉ ูุชุนุฑู ุนูููู
|
|
|
|
335 |
|
00:30:44,190 --> 00:30:48,590 |
|
ุจุณูููุฉุ ููู
ู
ุง ูุญุตู ููู Decrease expression ููMSC |
|
|
|
336 |
|
00:30:48,590 --> 00:30:54,770 |
|
Determinants ุนูู ุณุทุญ ุงู tumor cell ุจูููู ูุณููุฉ ู
ู |
|
|
|
337 |
|
00:30:54,770 --> 00:30:59,450 |
|
ูุณุงุฆู ุชูุฑุจ ุงูุฎููุฉ ุงูุณุฑุทุงููุฉ from the action of |
|
|
|
338 |
|
00:30:59,450 --> 00:31:05,450 |
|
cytokine transfection |
|
|
|
339 |
|
00:31:05,450 --> 00:31:12,470 |
|
of tumor cell with genes coding for cytokine ุฒู IL |
|
|
|
340 |
|
00:31:12,470 --> 00:31:21,430 |
|
-117 ููุงู
ุงูุชุฑููุฑูู ู
ุงุดูุ ูุจุนุฏ ุฐูู ุฑุฌุนูู
ู
ุงุดู |
|
|
|
341 |
|
00:31:21,430 --> 00:31:22,290 |
|
ููู
ุฑูุถ |
|
|
|
342 |
|
00:31:25,210 --> 00:31:32,150 |
|
ุฃููู ุงู tumor-pairing mice ุฃุธูุฑุช ูุชุงุฆุฌ ุฌูุฏุฉ ูู |
|
|
|
343 |
|
00:31:32,150 --> 00:31:38,150 |
|
ุงูู inhibition of growth of tumorุ ุทูุจุ |
|
|
|
344 |
|
00:31:38,150 --> 00:31:43,430 |
|
ุฅูุด ุงูู limitation of effectiveness of immune |
|
|
|
345 |
|
00:31:43,430 --> 00:31:47,090 |
|
response against tumorุ ูููุง ุจูุนุฑู ุฃูู ู
ุน ูุฌูุฏ |
|
|
|
346 |
|
00:31:47,090 --> 00:31:54,710 |
|
immune response ูุฃู tumor cell ุฃู tumor can growุ ู |
|
|
|
347 |
|
00:31:54,710 --> 00:32:02,310 |
|
ุจูุชุบูุจ ุนูู ุงูุฌูุงุฒ ุงูู
ูุงุนูุ ููุด ูุดูู ุฃููุฉ there is no |
|
|
|
348 |
|
00:32:02,310 --> 00:32:05,430 |
|
question ุฃู ูู ูุฌูุฏ ุงู immune responseุ ุงู immune |
|
|
|
349 |
|
00:32:05,430 --> 00:32:13,050 |
|
response ุจูููู ุดุบุงู ูู ูุฌูุฏ ุงู tumor ููู ุจุงูุฑุบู
|
|
|
|
350 |
|
00:32:13,050 --> 00:32:20,350 |
|
ู
ู ุฐูู ุงู tumor continue to growุ ูุทุจุนุง ุฏุฑุณูุง ุนุฏุฉ |
|
|
|
351 |
|
00:32:20,350 --> 00:32:21,330 |
|
ู
ููุงููุฒู
ุงุช |
|
|
|
352 |
|
00:32:23,960 --> 00:32:35,180 |
|
ุทุจุนุง ูุฐู ุจุชุชุนูู ุจุงู tumor cell ุฃู ุจ tumor and host |
|
|
|
353 |
|
00:32:35,180 --> 00:32:38,380 |
|
relationship |
|
|
|
354 |
|
00:32:38,380 --> 00:32:44,360 |
|
ูุดูู ุงูู
ููุงููุฒู
ุงุช ุงููู ุจุชุชุนูู ุจุงู tumorุ ูููู ุฅู ู
ู |
|
|
|
355 |
|
00:32:44,360 --> 00:32:47,540 |
|
ูุงุญุฏ failure of tumor to provide suitable target |
|
|
|
356 |
|
00:32:47,540 --> 00:32:52,040 |
|
ูุนูู ููู ุชุชุนุฑู ูุชุนุฑู ุนูููุง ุฌูุงุฒ ุงูู
ูุงุนุฉุ ุจุฏู ูููู |
|
|
|
357 |
|
00:32:52,040 --> 00:32:56,060 |
|
ููู targetุ ุจุฏู ูููู ููู antigenุ ูุดูู ุงููุณุงุฆู ุงูุชู |
|
|
|
358 |
|
00:32:56,060 --> 00:33:01,640 |
|
ุชุชูุฑุจ ู
ู ุฎูุงููุง ุงู tumor cell from the immune |
|
|
|
359 |
|
00:33:01,640 --> 00:33:06,020 |
|
responseุ ูููู ุฅู ู
ู ูุงุญุฏุ ุชุงููุจ antigen ููุจุชู ุจุชุทูุน |
|
|
|
360 |
|
00:33:06,020 --> 00:33:10,050 |
|
ูู ุงู antigenุงุช ุงููู ุนูู ุณุทุญูุง ูุจุงูุชุงูู ูู ุงู tumor |
|
|
|
361 |
|
00:33:10,050 --> 00:33:13,550 |
|
ุงูุชูุฌูู ู
ุด ู
ูุฌูุฏุฉุ ูููุจุฑู ุงุชุนุฑู ุนูููุง ุฌุฒุก ู
ููุงุ ูู
ุฑ |
|
|
|
362 |
|
00:33:13,550 --> 00:33:16,770 |
|
ุงุชููู lack of a C class one moleculeุ ุทุจ ู
ุง ูู ุฏู |
|
|
|
363 |
|
00:33:16,770 --> 00:33:21,970 |
|
ุนุจุงุฑุฉ ุนู presenting molecule ููุงูุชูุฌููุ deficient |
|
|
|
364 |
|
00:33:21,970 --> 00:33:25,510 |
|
of antigen processingุ ุฃุตูุง ู
ุงููุด ุงูุชูุฌูู ุนุดุงู |
|
|
|
365 |
|
00:33:25,510 --> 00:33:29,770 |
|
ูุนู
ูู processingุ antigenic modulation ุจูุบูุฑ ุงูุฌูุงุฒ |
|
|
|
366 |
|
00:33:29,770 --> 00:33:36,270 |
|
ุงูุฎููุฉ ุงูุณุฑุทุงููุฉ ูู ุงูุงูุชูุฌูู ุจุงุณุชู
ุฑุงุฑุ ูุจุงูุชุงูู |
|
|
|
367 |
|
00:33:36,270 --> 00:33:41,000 |
|
ุจูุตูุฑ ูู ุงููุ ุฎูู ูู ุงูุชุนุฑู ุนูููุ antigenic masking |
|
|
|
368 |
|
00:33:41,000 --> 00:33:46,740 |
|
of the tumorุ ููู
ูุบุทู ุงูุงูุชูุฌูู ููุฑููุง ุงูุฎููุฉ |
|
|
|
369 |
|
00:33:46,740 --> 00:33:51,420 |
|
ุงูุณุฑุทุงููุฉ ุจุฑุถู ูุงุชุณุชุทูุน ุฃู ุชุชุนุฑู ุนูููุงุ resistance |
|
|
|
370 |
|
00:33:51,420 --> 00:33:55,260 |
|
of tumor cell to tumor seedal effector pathwayุ ุจุนุฏ |
|
|
|
371 |
|
00:33:55,260 --> 00:34:01,540 |
|
ุงูุฎููุฉ ุงูุณุฑุทุงููุฉ ุจุชูุงูู
any ุงููู ูู tumor seedal |
|
|
|
372 |
|
00:34:01,540 --> 00:34:02,620 |
|
effector pathway |
|
|
|
373 |
|
00:34:05,230 --> 00:34:10,050 |
|
ูุงูููุน ุงูุซุงูู ุฃู ุงูุนุงู
ู ุงูุซุงูู failure of tumor to |
|
|
|
374 |
|
00:34:10,050 --> 00:34:18,910 |
|
induce ineffective immune responseุ ุทุจุนุง ุฒู ู
ุง |
|
|
|
375 |
|
00:34:18,910 --> 00:34:29,170 |
|
ูููุง ุจูุตูุฑ ููู ูุดู ูู ุงููู ูู ุชูููู ุงู immune |
|
|
|
376 |
|
00:34:29,170 --> 00:34:29,890 |
|
response |
|
|
|
377 |
|
00:34:32,510 --> 00:34:36,530 |
|
ูุทุจุนุง ูุฌูุฏ ุงูู tumor ูุนูู ุฃูู ูุงุฒู
ูุตูุฑ ููู |
|
|
|
378 |
|
00:34:36,530 --> 00:34:40,450 |
|
response ุจุนุถ ุงูู
ุฑุงุช ุจููุดู ุงูู tumor ูู ุชุญููู ูุฐู |
|
|
|
379 |
|
00:34:40,450 --> 00:34:43,930 |
|
ุงูุธุงูุฑุฉ ุจุณุจุจ ูู ุฐูู lack of antigenic epitopes |
|
|
|
380 |
|
00:34:43,930 --> 00:34:48,770 |
|
ู
ุงููุด epitopes ูู
ุฑุฉ ุงุซููู decrease MSC or tumor |
|
|
|
381 |
|
00:34:48,770 --> 00:34:52,970 |
|
antigen expression ูู
ุฑุฉ ุซูุงุซุฉ ู
ุงููุด costimulatory |
|
|
|
382 |
|
00:34:52,970 --> 00:34:56,570 |
|
signal ูู
ุฑุฉ ุฃุฑุจุนุฉ production of inhibitory |
|
|
|
383 |
|
00:34:56,570 --> 00:35:02,390 |
|
substance ูู ุจุนุถ ุงูุตูุชุฑูุงูู ุงููู ููุดูููุง ูู
ุฑุฉ ุฎู
ุณุฉ |
|
|
|
384 |
|
00:35:02,390 --> 00:35:07,230 |
|
shedding of tumor antigen in the surrounding area |
|
|
|
385 |
|
00:35:07,230 --> 00:35:10,690 |
|
ุฃู in the blood ูุจุงูุชุงูู ุจูุตูุฑ ูู tolerance ููู |
|
|
|
386 |
|
00:35:10,690 --> 00:35:18,250 |
|
antigen ูู ุงูุฌุณู
ูู
ุฑุฉ ุณุชุฉ ุงููู ูู induction of T |
|
|
|
387 |
|
00:35:18,250 --> 00:35:24,550 |
|
cell signaling defect by tumor burden ู
ุงููุด cell |
|
|
|
388 |
|
00:35:24,550 --> 00:35:32,170 |
|
signal ุทูุจ ูุฐุง ู
ุง ูุชุนูู ุจุงูู tumor ูุดูู ู
ุง ูุชุนูู ุจุฅูุด |
|
|
|
389 |
|
00:35:32,170 --> 00:35:35,050 |
|
ุจุงูู host |
|
|
|
390 |
|
00:35:46,230 --> 00:35:50,450 |
|
failure of the host to respond to antigenic tumor |
|
|
|
391 |
|
00:35:50,450 --> 00:35:54,430 |
|
ูุงููุง ุจุนุฏ ู
ุฑุงุช ุจูููู ููู neuro suppression or |
|
|
|
392 |
|
00:35:54,430 --> 00:36:01,530 |
|
deficiency of the host ุจุฅุดู ุจุชุดู
ู apoptosis ู |
|
|
|
393 |
|
00:36:01,530 --> 00:36:05,810 |
|
signaling defect of the T cell ูุงูุณุจุจ ูู ุฐูู ูุฌูุฏ |
|
|
|
394 |
|
00:36:05,810 --> 00:36:08,470 |
|
carcinogenic agent ูุฅู ูุงู physical or chemical |
|
|
|
395 |
|
00:36:08,470 --> 00:36:15,410 |
|
agent or infection or even age ุขู ูุนูู ุงููุงุณ |
|
|
|
396 |
|
00:36:15,410 --> 00:36:19,030 |
|
ุงูุงุฎุชูุงุฑูุฉ ูู
ุงู ู
ู
ูู ู
ุง ูุดูู ูู
ุฑุฉ ุงุซููู deficient |
|
|
|
397 |
|
00:36:19,030 --> 00:36:22,170 |
|
presentation of tumor antigen ู
ุงูู by the host |
|
|
|
398 |
|
00:36:22,170 --> 00:36:24,530 |
|
antigen presenting cell ู
ุง ูุฏุฑุช ุงูู antigen |
|
|
|
399 |
|
00:36:24,530 --> 00:36:28,430 |
|
presenting cell ุงููู ูู ุชุนู
ู antigen presentation |
|
|
|
400 |
|
00:36:28,430 --> 00:36:33,070 |
|
ููู tumor antigen ุงููู
ุฑุฉ ุซูุงุซุฉ failure of host |
|
|
|
401 |
|
00:36:33,070 --> 00:36:37,970 |
|
effector to reach tumor ุจุนุถ ุงูู
ุฑุงุช ุจูููู ุงูู tumor |
|
|
|
402 |
|
00:36:37,970 --> 00:36:41,790 |
|
ู
ุชุฎุจู ูู ุฃู
ุงูู ูุง ูุณุชุทูุน ุฃู ุชุตู ุฅูููุง ุฌูุงุฒ ุงูู
ูุงุนุฉ |
|
|
|
403 |
|
00:36:41,790 --> 00:36:47,640 |
|
ุฒู ุงูู stromer carrier ู
ุฑุฉ ุฎู
ุณุฉ host failure of host |
|
|
|
404 |
|
00:36:47,640 --> 00:36:54,420 |
|
to kill variant tumor cell because of dominant |
|
|
|
405 |
|
00:36:54,420 --> 00:36:58,760 |
|
immunodominant antigen on parental tumor cell ุทุจุนุง |
|
|
|
406 |
|
00:36:58,760 --> 00:37:05,100 |
|
ุจูููู ุงูู antigen ูู ูุฐู ุงูุญุงูุฉ dominant |
|
|
|
407 |
|
00:37:05,100 --> 00:37:15,530 |
|
antigen ุนูู ุงูู parental ุงููู ูู tumor cell |
|
|
|
408 |
|
00:37:15,530 --> 00:37:22,610 |
|
immunodiagnosis |
|
|
|
409 |
|
00:37:22,610 --> 00:37:27,750 |
|
ููุด ุจุฏูุง ูุนู
ู immunodiagnosis ูุงููุง ูู ูุฏููู ูู
ุฑุง |
|
|
|
410 |
|
00:37:27,750 --> 00:37:31,090 |
|
ูุงุญุฏ to detect antigen specific to tumor and cell |
|
|
|
411 |
|
00:37:31,090 --> 00:37:37,670 |
|
ูู
ุฑุง ุงุซููู ูุชูููู
|
|
|
|
412 |
|
00:37:37,670 --> 00:37:42,000 |
|
lost immune response to the tumor ุทุจุนุง ุงูู tumor |
|
|
|
413 |
|
00:37:42,000 --> 00:37:46,220 |
|
cell ุจู express cytoplasmic ุฃู cell surface ุฃู |
|
|
|
414 |
|
00:37:46,220 --> 00:37:50,100 |
|
secreted product that are different in nature and |
|
|
|
415 |
|
00:37:50,100 --> 00:37:53,340 |
|
or quantity from those produced by their normal |
|
|
|
416 |
|
00:37:53,340 --> 00:37:56,800 |
|
counterpart ุทุจูุนู ุฌุฏุง tumor cell ุญุชู ุชูุฑุฒ ูุฐู |
|
|
|
417 |
|
00:37:56,800 --> 00:37:59,720 |
|
ุงูุญุงุฌุงุช ุณูุงุก ูุงูุช cytoplasmic ุฃู ุนูู ุงูู cell |
|
|
|
418 |
|
00:37:59,720 --> 00:38:05,040 |
|
surface ุฃู ูู secreted product ุจุชุฎุชูู ุงุฎุชูุงู ููู |
|
|
|
419 |
|
00:38:05,040 --> 00:38:11,510 |
|
ุนู ุงูู normal counterpart ุจุณุจุจ ุนุฏุฏ ุงูุงูุชุฌูููุงุช |
|
|
|
420 |
|
00:38:11,510 --> 00:38:13,850 |
|
ุงูุตุญูุญุฉ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
|
421 |
|
00:38:13,850 --> 00:38:19,490 |
|
ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู |
|
|
|
422 |
|
00:38:19,490 --> 00:38:22,970 |
|
ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
|
423 |
|
00:38:22,970 --> 00:38:23,110 |
|
ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
|
424 |
|
00:38:23,110 --> 00:38:23,130 |
|
ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู |
|
|
|
425 |
|
00:38:23,130 --> 00:38:23,310 |
|
ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญูุญ |
|
|
|
426 |
|
00:38:23,310 --> 00:38:37,910 |
|
ููู
ุฑู ุงูุตุญูุญ ููู
ุฑู ุงูุตุญ |
|
|
|
427 |
|
00:38:38,340 --> 00:38:42,300 |
|
ูุญุตููุง ุนูู ู
ูููููููุงู ุงูุงูุชูุจุงุฏู ูุฐู ุงูุงูุชูุจุงุฏู |
|
|
|
428 |
|
00:38:42,300 --> 00:38:46,320 |
|
ูุณุชุฎุฏู
ูุง ูุฃู
ู ุจูุณู
ููุง immunodiagnostic antibody |
|
|
|
429 |
|
00:38:46,320 --> 00:38:50,840 |
|
for immunodiagnosis of a human tumor and their |
|
|
|
430 |
|
00:38:50,840 --> 00:38:58,700 |
|
products these are widely used as reliable |
|
|
|
431 |
|
00:38:58,700 --> 00:39:05,660 |
|
immunodiagnostic procedure ููุดูู ุงูุฃู
ุซูุฉ ุนูู ุฐูู |
|
|
|
432 |
|
00:39:06,870 --> 00:39:10,470 |
|
ูุงููุง detection of myeloma protein produced by |
|
|
|
433 |
|
00:39:10,470 --> 00:39:14,570 |
|
plasma cell tumor ุทุจุนุง ูู ุงูู multiple myeloma ููุง |
|
|
|
434 |
|
00:39:14,570 --> 00:39:18,690 |
|
ุจูุนุฑู ุฃูู ูู antibody ุจุชุชููู ู
ู plasma cell ูู ูุฐู |
|
|
|
435 |
|
00:39:18,690 --> 00:39:22,990 |
|
ุงูุญุงูุฉ ูุจุงูุชุงูู detection of these proteins or |
|
|
|
436 |
|
00:39:22,990 --> 00:39:28,430 |
|
antibody can be diagnostic ุทุจุนุง ู
ุซุงู ุขุฎุฑ ูู |
|
|
|
437 |
|
00:39:28,430 --> 00:39:30,410 |
|
multiple myeloma ุฃูุถุง ูู light chain |
|
|
|
438 |
|
00:39:30,410 --> 00:39:34,230 |
|
immunoglobulin ูุดูููุง ูู ุงูู pensions protein ูู ุงูู |
|
|
|
439 |
|
00:39:34,230 --> 00:39:37,430 |
|
urine ูุฐุง ุนุจุงุฑุฉ ุนู Diagnostic Criteria ุฃูุถูุง |
|
|
|
440 |
|
00:39:37,430 --> 00:39:42,450 |
|
Indication ุนูู Plasma Cell Tumor ุฃู
ุง ุงุซููู |
|
|
|
441 |
|
00:39:42,450 --> 00:39:45,450 |
|
Detection ู Alpha-Feto Protein ูู ู
ู ูุนุฑู ุฃู ุงูู |
|
|
|
442 |
|
00:39:45,450 --> 00:39:48,630 |
|
Alpha-Feto Protein ูู ุนุจุงุฑุฉ ุนู ุจุฑูุชูู ู
ูุฌูุฏ ูู ุงูู |
|
|
|
443 |
|
00:39:48,630 --> 00:39:53,650 |
|
Fetal Serum ููู ุจุงูุชุงูู ุจุนุฏ ููุงุฏุฉ ุงูู level ุจูููู |
|
|
|
444 |
|
00:39:53,650 --> 00:39:59,670 |
|
ุนุงูู ููู ุจูุจุฏุฃ ููุฒู ุจุณุฑุนุฉ ูุบุงูุฉ ุนุดุฑูู ูุงูู ุฌุฑุงู
|
|
|
|
445 |
|
00:39:59,670 --> 00:40:05,450 |
|
ุจูุฑู
ูู ุทุจุนุง ูู ุฃูุซุฑ ู
ู ูู ุญุงูุงุช ู
ุฑุถูุฉ ุฒู ุงูู |
|
|
|
446 |
|
00:40:05,450 --> 00:40:10,370 |
|
ovarian and testicular embryonal a non cancerous |
|
|
|
447 |
|
00:40:10,370 --> 00:40:15,410 |
|
hepatic disorder ูุฐุง ุงูู level of alpha-fetoprotein |
|
|
|
448 |
|
00:40:15,410 --> 00:40:23,170 |
|
ุจูุฒูุฏ ูุงููุง ุฅุฐุง ุฒุงุฏ ูุตู ุฎู
ุณู
ูุฉ ูุฃูู ูุงูู ุฌุฑุงู
|
|
|
|
449 |
|
00:40:23,170 --> 00:40:29,620 |
|
ุจูุฑู
ูู ูุฐุง ุจูุนูู ุนูู ุฃู ูู tumor ุจููุชุฌ Alpha |
|
|
|
450 |
|
00:40:29,620 --> 00:40:35,480 |
|
-Fetoprotein ูู
ุชุงุจุนุฉ ุงูู Alpha-Fetoprotein ุจูุนุฑููุง |
|
|
|
451 |
|
00:40:35,480 --> 00:40:41,080 |
|
ุฅุฐุง ูุงู ุงูู tumor ุจุณูู ุฑูุฌูุดู ุฃู ุฑูุจุฑููุฌุดู CAA |
|
|
|
452 |
|
00:40:41,080 --> 00:40:44,920 |
|
ุงุญูุง ูููุงูุง ุฏู ุนุจุงุฑุฉ ุนู ุงูู glycorrotine ูู ุงููุถุน |
|
|
|
453 |
|
00:40:44,920 --> 00:40:50,640 |
|
ุงูุทุจูุนู ุจููุชุฌ by gastrointestinal tract ูุฎุตูุตุง ุงูู |
|
|
|
454 |
|
00:40:50,640 --> 00:40:56,550 |
|
colon ูููู
ูุตูุฑ ุงูุฎูุงูุง ุณุฑุทุงููุฉ ุงูู CA ูุชู
ุฅุทูุงููุง |
|
|
|
455 |
|
00:40:56,550 --> 00:41:03,350 |
|
ูู ุงูุฏู
ุฅุฐุง ุฒุงุฏุช ุงูุชุฑููุฒ ุนูู 2.5 ูุงูู ุฌุฑุงู
ุจูุฑู
ูู |
|
|
|
456 |
|
00:41:03,350 --> 00:41:08,230 |
|
ุจูุนูู ูู ู
ุงูู ูุงูุณู ุทุจุนุง ุงูู high level ูู
ุงู ูุฌุฏูู |
|
|
|
457 |
|
00:41:08,230 --> 00:41:13,290 |
|
ูู non cancerous disease |
|
|
|
458 |
|
00:41:13,290 --> 00:41:17,690 |
|
ุฒู ุณูุฑูุณุฒ ู ุงูู inflammatory disease of the |
|
|
|
459 |
|
00:41:17,690 --> 00:41:19,410 |
|
intestinal tract and lung |
|
|
|
460 |
|
00:41:23,990 --> 00:41:30,070 |
|
PCSA ุจุฑุงูุฌ ูุงูููููุซูู ู
ูุฌูุฏ ูู ุงูู ductal |
|
|
|
461 |
|
00:41:30,070 --> 00:41:36,330 |
|
epithelial cells of the prostate ุฅุฐุง ูุงู ุชุฑููุฒ ุจู |
|
|
|
462 |
|
00:41:36,330 --> 00:41:40,030 |
|
8 ุฅูู 10 ูุงูู ุฌุฑุงู
ูู ุงูุจูุฏ ุจูุนูู ุฃูู ููู prostate |
|
|
|
463 |
|
00:41:40,030 --> 00:41:48,250 |
|
cancer ุงูู cancer antigen 125 CA125 |
|
|
|
464 |
|
00:41:50,660 --> 00:41:56,280 |
|
ุทุจุนุง ูุฐุง ุจุฑุนุงู tumor marker ูุณุชุฎุฏู
for monitoring |
|
|
|
465 |
|
00:41:56,280 --> 00:42:01,880 |
|
the therapy of ovarian cancer C125 |
|
|
|
466 |
|
00:42:01,880 --> 00:42:06,760 |
|
ุฃูุถุง ุจูุฒูุฏ during peritoneal inflammatory process |
|
|
|
467 |
|
00:42:06,760 --> 00:42:10,600 |
|
ููู other marker ูู ุจุฑุนุงู pan marker ุจูุณู
ู pan |
|
|
|
468 |
|
00:42:10,600 --> 00:42:17,410 |
|
carcinoma marker ุงููู ูู P72.3 ูู ุจุฑุนุงู Monoclonal |
|
|
|
469 |
|
00:42:17,410 --> 00:42:23,730 |
|
Antibody That Recognize All Carcinoma In Human ูู |
|
|
|
470 |
|
00:42:23,730 --> 00:42:27,710 |
|
ุจุฑุนุงู Monoclonal Antibody ุงุณุชุฎุฏู
ูุง ููู ุงูุชุนุฑู ุนูู |
|
|
|
471 |
|
00:42:27,710 --> 00:42:34,250 |
|
ูู ุฃููุงุน ุงููุงุฑุณูููู
ุง ูู ุงูุฌุณู
ู
ู ุงูุณุจุจ ุจูุณุชุฎุฏู
ูุง |
|
|
|
472 |
|
00:42:34,250 --> 00:42:37,570 |
|
ุทุจุนุง numerous attempts have been made to treat |
|
|
|
473 |
|
00:42:37,570 --> 00:42:41,730 |
|
cancer in animal and human by immunological means |
|
|
|
474 |
|
00:42:42,280 --> 00:42:45,880 |
|
ููู ููุฃุณู ุงูุดุฏูุฏ ุงูููู
ุงูู immunotherapy ูู
ูุชู
|
|
|
|
475 |
|
00:42:45,880 --> 00:42:51,180 |
|
ุชุญุฑูุฑูุง ูุชููู ุชุฌุงุฑุจ ู
ููุฏุฉ ููุณุฑุทุงู ุณูุงุก ูุงูุช ุงุณุชุฎุฏู
ุช |
|
|
|
476 |
|
00:42:51,180 --> 00:42:54,740 |
|
ูุญุงููุง ุฃู ุงุณุชุฎุฏู
ุช in combination with chemotherapy |
|
|
|
477 |
|
00:42:54,740 --> 00:43:00,000 |
|
and radiotherapy ุฃู even surgery ุงูููู
currently |
|
|
|
478 |
|
00:43:00,000 --> 00:43:06,460 |
|
ููู ูุนูู ู
ุฌู
ูุนุฉ ูุจูุฑุฉ ู
ู ุงูุฃุจุญุงุซ ู ุงูุงุณุชุฑุงุชูุฌูุงุช |
|
|
|
479 |
|
00:43:06,460 --> 00:43:12,110 |
|
ูุถุนุช for experimental immunotherapy of tumor |
|
|
|
480 |
|
00:43:12,110 --> 00:43:19,810 |
|
ููุงุณุชุฎุฏุงู
ูุทุจุนุง ุงุณุชุฎุฏู
ููุง ู
ู ุฎูุงู ุฏุฑุงุณุชูู
ูููููุฉ |
|
|
|
481 |
|
00:43:19,810 --> 00:43:27,430 |
|
ูุณุงุฆู ุชูุดูุท ุฃู ูุชู ุงูุฎูุงูุง ุงูู
ูุงุนูุฉ ุชูุดูุท ุงูุฎูุงูุง |
|
|
|
482 |
|
00:43:27,430 --> 00:43:30,750 |
|
ุงูู
ูุงุนูุฉ ู ููููุฉ ูุชููุง ุงูุฎูุงูุง ุงูุณุฑุทุงููุฉ ูุฏู |
|
|
|
483 |
|
00:43:30,750 --> 00:43:32,450 |
|
ู
ููุงููุฒู
ุงุช ูููุง ุงุญูุง ุนุงุฑููููุง |
|
|
|
484 |
|
00:43:37,710 --> 00:43:47,360 |
|
ุฃู
ุง ุจูุดุท ุงูู
ููุงูุฒู
ูุจุงูุชุงูู ุจูุฎุชู ุจุทุฑููุฉ ุฃูุถู ูุนูู |
|
|
|
485 |
|
00:43:47,360 --> 00:43:52,220 |
|
ุงูุฎูุงูุง ุฏู ูููุง ุจููุดุทูุง ุฃู ู
ุญูู ุงููู ูู |
|
|
|
486 |
|
00:43:52,220 --> 00:43:56,500 |
|
cytotoxic telephosite whatever ุญุชุชุทุฑู ุงูู ูุฐู |
|
|
|
487 |
|
00:43:56,500 --> 00:44:00,700 |
|
ุงูู
ููุงููุฒู
ุงุช ูุงุญุฏ ูุงุญุฏ tumor specific monoclonal |
|
|
|
488 |
|
00:44:00,700 --> 00:44:08,340 |
|
antibody ุงุณุชุฎุฏู
ูุง ุฃูุช ุฏู anti CD20 ูุนูุงุฌ ุจุนุถ |
|
|
|
489 |
|
00:44:08,340 --> 00:44:14,920 |
|
ุงููููููู
ุฉ Anti human ุฅูู ุจุฏูู ู
ู ุงูู Growth Factor |
|
|
|
490 |
|
00:44:14,920 --> 00:44:17,700 |
|
Receptor for treatment of certain patients with |
|
|
|
491 |
|
00:44:17,700 --> 00:44:22,420 |
|
breast and ovarian cancerุ ุทุจุนุง ูุฐู ุงูุงูุชูุจุงุฏู ูุงู |
|
|
|
492 |
|
00:44:22,420 --> 00:44:27,600 |
|
ุจุฏูู Cytolysis either by Anky cell ู
ู ุฎูุงู ุงูู FC |
|
|
|
493 |
|
00:44:27,600 --> 00:44:34,260 |
|
receptor ูู
ููุงูุฒู
ุงูู ADCC ุฃู by complement |
|
|
|
494 |
|
00:44:34,260 --> 00:44:39,740 |
|
activation ูSurface Cytolysis attachment of toxin |
|
|
|
495 |
|
00:44:39,740 --> 00:44:45,000 |
|
such as ricin or radioactive isotopes ุจุฑุจุทูุง ูุฐุง |
|
|
|
496 |
|
00:44:45,000 --> 00:44:51,460 |
|
ุงูู toxin ุจุงูู antibody ู ุจูุญูููู ูู ุงูุฅูุณุงู |
|
|
|
497 |
|
00:44:51,460 --> 00:44:55,380 |
|
ูุจุงูุชุงูู ุจูุจูู ูู
ุดู ูุบุฉ muscle specific for tumor |
|
|
|
498 |
|
00:44:55,380 --> 00:44:58,000 |
|
cell ูุจุงูุชุงูู ุจูุตู ุงูู tumor cell ู ููุงู ุจูุนู
ู |
|
|
|
499 |
|
00:44:58,000 --> 00:45:04,000 |
|
direct killing ูู ุงูู cell xenogenic antibody ุทุจุนุง |
|
|
|
500 |
|
00:45:04,000 --> 00:45:10,120 |
|
ุฃุฎุฐูุง ู
ู ุงูู mouse ุงูุชูุจุงุฏู ุทุจุนุง ูู ุนุจุงุฑุฉ ุนู ูุงูุณ |
|
|
|
501 |
|
00:45:10,120 --> 00:45:16,160 |
|
ุฃูุชูุจุงุฏู ููู ุงูู Fc portion ุจูุฑู ููู
ุจูููู ุฏู ุฃููู |
|
|
|
502 |
|
00:45:16,160 --> 00:45:20,580 |
|
ุชูููููุฌู ุฎูููุง humanize their constant region |
|
|
|
503 |
|
00:45:20,580 --> 00:45:26,860 |
|
ูุจุงูุชุงูู ุญูู ุนุดุงู ูููููู
ุงูู immunogenicity ุชุจุนุชู |
|
|
|
504 |
|
00:45:26,860 --> 00:45:31,560 |
|
ุจุงู specific ุงูุชูุจุงุฏู ูุฐุง ุนุจุงุฑุฉ ุนู ุงูุชูุจุงุฏู |
|
|
|
505 |
|
00:45:31,560 --> 00:45:38,580 |
|
ุงูุงูุชูุจุงุฏู ูู two Fab ูุงุญุฏุฉ ุฎูููุง ุทุจุนุง ุจุฑุถู by |
|
|
|
506 |
|
00:45:38,580 --> 00:45:42,240 |
|
recombinant DNA technology ุงูู
ูุถูุน ูุงุญุฏุฉ ุฎูููุง |
|
|
|
507 |
|
00:45:42,240 --> 00:45:46,180 |
|
specific for tumor antigen ูุงูุชุงููุฉ specific for |
|
|
|
508 |
|
00:45:46,180 --> 00:45:52,480 |
|
ุงูุด for T cell ุฃู NK cell ุฃู whatever ู
ุงุดู |
|
|
|
509 |
|
00:45:52,480 --> 00:45:59,890 |
|
ูุจุงูุชุงูู ูุฑุจูุง ุงูู tumor cell ู
ู ุงูุฎููุฉ ุงูู
ูุงุนูุฉ |
|
|
|
510 |
|
00:45:59,890 --> 00:46:02,850 |
|
ุงููู ูู ุงูู cytotoxic T- lymphocyte ุฃู ุงูุงููู ุณูู |
|
|
|
511 |
|
00:46:02,850 --> 00:46:09,110 |
|
ุฅุฐุง ูุงู specific ููู Fc portion ุฃู Fc receptor ุงููู |
|
|
|
512 |
|
00:46:09,110 --> 00:46:12,530 |
|
ู
ูุฌูุฏ ุนูู ุณุทุญ ุงูุงููู ุณูู ูุจุงูุชุงูู ุงูุงููู ุณูู ุงูููู
|
|
|
|
513 |
|
00:46:12,530 --> 00:46:19,350 |
|
ูุฑุจ both cells ุณูุงุก ุงูู cytotoxic ุฃู ุงูุงููู ุณูู ุดุฑุท |
|
|
|
514 |
|
00:46:19,350 --> 00:46:24,620 |
|
ูุฌุงุญ ุงููู ูู ูุธููุชูุง ุงููู ูู cell to cell contact |
|
|
|
515 |
|
00:46:24,620 --> 00:46:27,700 |
|
ููู ูุฑูุจูุง ุงูุฎููุฉ ู
ู ุจุนุถ ูุจุงูุชุงูู ุจูุญุตู ูู direct |
|
|
|
516 |
|
00:46:27,700 --> 00:46:34,820 |
|
license ุงูู recombinant diffusion protein ุงููู ูู |
|
|
|
517 |
|
00:46:34,820 --> 00:46:41,260 |
|
ุจุนุถ ุงูู
ุฑุงุช ุจูุนู
ููุง protein ุนุจุงุฑุฉ ุนู cytokine ู
ุน |
|
|
|
518 |
|
00:46:41,260 --> 00:46:46,550 |
|
antitumor antibody ูุจูุณู
ูู immunocytokine immuno |
|
|
|
519 |
|
00:46:46,550 --> 00:46:50,450 |
|
ูุนูู ุงูุชูุจุงุฏู ู cytokine ู
ู immunoglobulin ุทุจุนุง ู |
|
|
|
520 |
|
00:46:50,450 --> 00:46:54,250 |
|
cytokine ู
ู cytokine ุจูุนู
ููููู
ุนูู ุดูู ุจุฑูุชูู ู |
|
|
|
521 |
|
00:46:54,250 --> 00:46:58,490 |
|
ุจูููููุง as a fusion protein concentrate ูุจุงูุชุงูู |
|
|
|
522 |
|
00:46:58,490 --> 00:47:05,170 |
|
ุจูุตูุฑ ุจูุดุชุบู ุนูู ุงูู tumor cell ุจุดูู ุฃูุถู ุณุงุนุฉ |
|
|
|
523 |
|
00:47:05,170 --> 00:47:12,280 |
|
ุชูุณู ุชููููููุณุงุนุฉ ุชุชุงุฎุฏ ู ุจุชุชูู
ู ุจุฑุงู
ุงุดู ูุฐู |
|
|
|
524 |
|
00:47:12,280 --> 00:47:17,940 |
|
ุงูุฎูุงูุง ุชุณุชุทูุน ุฃู ุชูุชู ู
ุจุงุดุฑุฉ ุงูู tumor cell ู |
|
|
|
525 |
|
00:47:17,940 --> 00:47:23,380 |
|
ุฎุตูุตุง ุฃูู ุนูุฏูุง ุงููุฏุฑุฉ ุฃููุง ุชุชููู cost emulatory |
|
|
|
526 |
|
00:47:23,380 --> 00:47:30,840 |
|
molecule ุฒู CDAT86 ุฃู cytokine ุทุจุนุง ุทุจุนุง ุทุจุนุง |
|
|
|
527 |
|
00:47:30,840 --> 00:47:38,980 |
|
ุทุจุนุง |
|
|
|
528 |
|
00:47:38,980 --> 00:47:40,920 |
|
ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง |
|
|
|
529 |
|
00:47:40,920 --> 00:47:44,620 |
|
ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง ุทุจุนุง |
|
|
|
530 |
|
00:47:47,550 --> 00:47:51,530 |
|
ุจูุดุทููุง ุจุญูู ุฃู ุงููdendritic cell already ู
ุฑุชุจุท |
|
|
|
531 |
|
00:47:51,530 --> 00:47:55,530 |
|
ุจุงุด ู
ู ุฎูุงู MHC class 1 ู
ูููููููุฉ ุนูู ุงูุณุทุญุฉ ุจุงู |
|
|
|
532 |
|
00:47:55,530 --> 00:48:01,310 |
|
antigenic peptide ุฃู tumor antigen ูุจุงูุชุงูู ุจูุตูุฑ |
|
|
|
533 |
|
00:48:01,310 --> 00:48:08,410 |
|
ุชุนุฑู ุฃู ู
ุชูุดูุท ููุชูุงุชูู ุณุงูุชูุชูุณูู ููู
ููุณุงูุช ุฃูุซุฑ |
|
|
|
534 |
|
00:48:08,410 --> 00:48:12,170 |
|
ุฅุฐุง ูุฐู highly efficient antigen presenting cell |
|
|
|
535 |
|
00:48:12,170 --> 00:48:18,490 |
|
normally express high level of cell surface ูุจุงูุชุงูู |
|
|
|
536 |
|
00:48:18,490 --> 00:48:25,890 |
|
ุจูุตูุฑ ููู ูุดุงุท ุฃูุซุฑ ูู T-cells.Dentritic cells are |
|
|
|
537 |
|
00:48:25,890 --> 00:48:31,630 |
|
either directly loaded ุจุงูุจูุจุชุงูุฏ ุฏู ุจูุญู
ููุง |
|
|
|
538 |
|
00:48:31,630 --> 00:48:37,550 |
|
ู
ุจุงุดุฑุฉ ุจุงูุจูุจุชุงูุฏ ุงูู tumor ุจูุจุชุงูุฏ ูุนูู ุฎูุงู tumor |
|
|
|
539 |
|
00:48:37,550 --> 00:48:40,730 |
|
cell lysate ุฃู |
|
|
|
540 |
|
00:48:41,970 --> 00:48:46,030 |
|
ูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
541 |
|
00:48:46,030 --> 00:48:47,070 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
542 |
|
00:48:47,070 --> 00:48:51,950 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
543 |
|
00:48:51,950 --> 00:48:55,450 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
544 |
|
00:48:55,450 --> 00:49:00,250 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
545 |
|
00:49:00,250 --> 00:49:00,630 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
546 |
|
00:49:00,630 --> 00:49:03,210 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู |
|
|
|
547 |
|
00:49:03,210 --> 00:49:11,590 |
|
ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏููุงูู ุชุชุนุงู
ู ู
ุน ู
ุตุงุฏุฑ ุฏูTumor |
|
|
|
548 |
|
00:49:11,590 --> 00:49:14,270 |
|
Antigen That Have Been Molecularly Characterized |
|
|
|
549 |
|
00:49:14,270 --> 00:49:19,070 |
|
Active Vaccination ููุณูุง ูุณุชุฎุฏู
Recombinant |
|
|
|
550 |
|
00:49:19,070 --> 00:49:22,990 |
|
Vaccine Which |
|
|
|
551 |
|
00:49:22,990 --> 00:49:26,770 |
|
Have Been Developed Using Vaccinia Listeria Or |
|
|
|
552 |
|
00:49:26,770 --> 00:49:33,310 |
|
Virus-Like Particle ุทุจุนุง ูุฐุง ุนุจุงุฑุฉ ุนู Active |
|
|
|
553 |
|
00:49:33,310 --> 00:49:41,480 |
|
Immunization ู
ู ุฎูุงู ุฃูุถุง ุญููู DNA ุจูุงุฒู
ูุฏ |
|
|
|
554 |
|
00:49:41,480 --> 00:49:48,080 |
|
Constructs ุงููู ูู DNA Vaccine ุจูุณู
ูู ูุงููุฏู ู
ู |
|
|
|
555 |
|
00:49:48,080 --> 00:49:57,020 |
|
ุฐูู ูู ุฃู ูููู specific ููู tumor antigen and |
|
|
|
556 |
|
00:49:57,020 --> 00:50:05,300 |
|
expressed by muscle cell ูุฃูุง ุฏูุน ุนู Vaccine ู
ูุฌูุฏ |
|
|
|
557 |
|
00:50:05,300 --> 00:50:06,880 |
|
ูู ุงูู DNA |
|
|
|
558 |
|
00:50:13,350 --> 00:50:17,030 |
|
which is unique to tumor antigen ูุนูู ูุจุงูุชุงูู |
|
|
|
559 |
|
00:50:17,030 --> 00:50:20,910 |
|
ุจูุตูุฑ ูู expression ููุฐุง ุงูู vaccine ูุฐุง ุงูู tumor |
|
|
|
560 |
|
00:50:20,910 --> 00:50:24,670 |
|
antigen ุฃูุซุฑ ูุจุงูุชุงูู ุจูุจูู ููู ุชูุดูุท ููุด ููุฎูุงูุง |
|
|
|
561 |
|
00:50:24,670 --> 00:50:28,610 |
|
ุงูู
ูุงุนูุฉ ุฃูุซุฑ ูู ุจุนุถ ุงูุญุงูุงุช ุดู ุจูุนู
ููุง ุจูุญูููุง |
|
|
|
562 |
|
00:50:28,610 --> 00:50:35,430 |
|
ุฌููุงุช ุฃูุถุง ู
ุณุฆููุฉ ุนู ุชุตููุน cytokine ุฒู GM-CSF IL2 |
|
|
|
563 |
|
00:50:35,430 --> 00:50:44,730 |
|
IL12 ูู ู
ุง ุฏูู if they introduced ุจูุญุณููุง |
|
|
|
564 |
|
00:50:44,730 --> 00:50:47,150 |
|
ุงูู presentation of tumor antigen by the enteric |
|
|
|
565 |
|
00:50:47,150 --> 00:50:56,430 |
|
cell at the site of injection augmentation |
|
|
|
566 |
|
00:50:56,430 --> 00:51:04,710 |
|
of specific anticancer immunity ูู ุทุจุนุง ูุฐุง by |
|
|
|
567 |
|
00:51:04,710 --> 00:51:12,580 |
|
stimulation of macrophage using BCG ุฃู ููุฑููู |
|
|
|
568 |
|
00:51:12,580 --> 00:51:20,080 |
|
ุจูุชูุฑูุงู
ุจุงุฑููู ุทุจุนุง ู
ุซุงู ุนูู ุฐูู ูู ุงุณุชุฎุฏุงู
ุงูู |
|
|
|
569 |
|
00:51:20,080 --> 00:51:24,060 |
|
BCG for treating patient with residual superficial |
|
|
|
570 |
|
00:51:24,060 --> 00:51:28,480 |
|
urinary bladder cancer ุจุญู ููู repeated |
|
|
|
571 |
|
00:51:28,480 --> 00:51:31,300 |
|
installation of live mycobacterium into the |
|
|
|
572 |
|
00:51:31,300 --> 00:51:38,490 |
|
bladder ู
ู ุฎูุงู ูุงุชูุชุฑ ุจุนุฏ ุงูุนู
ููุฉ ุจุนุฏ ู
ุง ูุนู
ููู ุงูู |
|
|
|
573 |
|
00:51:38,490 --> 00:51:46,570 |
|
section ููุง ุฃุซุจุชุช ูุฌุงุญ ูุจุชุนุชุจุฑ treatment of |
|
|
|
574 |
|
00:51:46,570 --> 00:51:54,970 |
|
choice for superficial bladder cancer ูุงุฒู
ูููู |
|
|
|
575 |
|
00:51:54,970 --> 00:52:01,630 |
|
ุฎุงุฑุฌู synthetic molecule ุฃูุถุง ูุจูู ููุฒ ุฒู ุงูุจุนูุฑุงู |
|
|
|
576 |
|
00:52:01,630 --> 00:52:09,710 |
|
ู ุงูู copilumar ู ุงูู maleic anhydride diphenyl ether ูุนุฏุฉ |
|
|
|
577 |
|
00:52:09,710 --> 00:52:16,530 |
|
these induce interferon production ูุงูุถุง ุจุนุถ ุงูู |
|
|
|
578 |
|
00:52:16,530 --> 00:52:19,690 |
|
herbal extracts have been used to stimulate the |
|
|
|
579 |
|
00:52:19,690 --> 00:52:28,650 |
|
immune response ู
ููุง ุงูุฌูุณููุฌ ูุงูุฅูุดูููุณูุง |
|
|
|
580 |
|
00:52:31,840 --> 00:52:35,500 |
|
ุงูู trials are also in progress on the effect of |
|
|
|
581 |
|
00:52:35,500 --> 00:52:40,820 |
|
various cytokines ุฒู ุงูู interferon alpha, beta, |
|
|
|
582 |
|
00:52:41,020 --> 00:52:47,220 |
|
gamma ุนูู ุงูู 1,2,2,3,4,5,12 tumor necrosis factor |
|
|
|
583 |
|
00:52:47,220 --> 00:52:54,540 |
|
ูุขุฎุฑ ุฅู
ุง singly or in combination on tumor |
|
|
|
584 |
|
00:52:54,540 --> 00:52:56,600 |
|
regression |
|
|
|
585 |
|
00:52:59,960 --> 00:53:04,680 |
|
ุนุดุฑุฉ lag cell ู ุงูู tumor infiltrate lymphocytes |
|
|
|
586 |
|
00:53:04,680 --> 00:53:09,680 |
|
ุฃูุถุง ุงุณุชุฎุฏู
ูู
ูู treatment of cancer with variable |
|
|
|
587 |
|
00:53:09,680 --> 00:53:15,020 |
|
results lag cells are produced in vitro by |
|
|
|
588 |
|
00:53:15,020 --> 00:53:21,060 |
|
cultivation ุจูุนู
ููููุง culturing ุจุงูู IL-2 ู |
|
|
|
589 |
|
00:53:21,060 --> 00:53:25,000 |
|
ุจูุนู
ููููุง reinfusion to the patient ู ุชุนู
ู |
|
|
|
590 |
|
00:53:25,000 --> 00:53:28,620 |
|
dramatic improvement in the have been used |
|
|
|
591 |
|
00:53:34,260 --> 00:53:37,700 |
|
ุฃูุถุง ุงูู documented success ูุงูุช ุฃูุถุง ู
ูุงูุฉ |
|
|
|
592 |
|
00:53:37,700 --> 00:53:42,940 |
|
ุจุงุณุชุฎุฏุงู
tumor infiltrate lymphocyte ูู
ุง ููููุงูุง |
|
|
|
593 |
|
00:53:42,940 --> 00:53:48,280 |
|
ูู
ุฑุถู ุนูุฏูู
melanoma ูุฌุฏูุง ุฃู ูุฐู ุงูู lymphocyte |
|
|
|
594 |
|
00:53:48,280 --> 00:53:53,140 |
|
ุทุจุนุง ู
ู
ูู ุชุชุงุฎุฏ by removal from tumor biopsy |
|
|
|
595 |
|
00:53:53,140 --> 00:53:58,640 |
|
expanded in vitro ูุนูู ูุจููููุง ูุฏููุง ููุจููููุง |
|
|
|
596 |
|
00:53:58,640 --> 00:54:04,380 |
|
culturing ูู ูุฌูุฏ IL-2 ูุฑุฌุนููุง ุซุงูู ูุนูู ุงูู
ุฑูุถ |
|
|
|
597 |
|
00:54:04,380 --> 00:54:09,600 |
|
ูุฌุฏูุง ุฃูู ููู Anti-Tumor Activity Higher Many |
|
|
|
598 |
|
00:54:09,600 --> 00:54:20,900 |
|
Times Than Lag Cell ู ูุฐู ูููุช ู
ู ุงูุนูุงุฌ |
|
|
|
599 |
|
00:54:20,900 --> 00:54:26,260 |
|
tumor immunoprophylaxis ูุนูู ุนุดุงู ูู
ูุน ุงููู ูู |
|
|
|
600 |
|
00:54:26,260 --> 00:54:29,460 |
|
prophylactic treatment for tumor |
|
|
|
601 |
|
00:54:35,430 --> 00:54:38,850 |
|
ุจุงุณุชุฎุฏุงู
ุชูููุฉ ุงู
ููููุฉ ูุนูู ุงู
ููููุฉ ุถุฏ ุงูููุฑูุณ |
|
|
|
602 |
|
00:54:38,850 --> 00:54:42,590 |
|
ุงูุฃูููุฌููููู ูุงูุช |
|
|
|
603 |
|
00:54:42,590 --> 00:54:47,330 |
|
ู
ูููู
ุฉ ูู ุงูููุจ ุญูุง ุฃููู
ูู ุงูููุฑูุณ ุงูุฃูููุฌููููู |
|
|
|
604 |
|
00:54:47,330 --> 00:54:52,850 |
|
ุฃูุถุง ุงู
ููููุฉ ุถุฏ ุนุถูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
|
605 |
|
00:54:52,850 --> 00:54:54,310 |
|
ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
|
606 |
|
00:54:54,310 --> 00:54:55,950 |
|
ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
|
607 |
|
00:54:55,950 --> 00:54:59,590 |
|
ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
|
608 |
|
00:54:59,590 --> 00:54:59,670 |
|
ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญููุงูุงุช |
|
|
|
609 |
|
00:54:59,670 --> 00:55:02,690 |
|
ุงูุญููุงูุงุช ุงูุญููุงูุงุช ุงูุญุฃู ุจูุนุทูุง tumor cell in |
|
|
|
610 |
|
00:55:02,690 --> 00:55:06,570 |
|
which replication has been blocked ู
ุงููุด |
|
|
|
611 |
|
00:55:06,570 --> 00:55:10,290 |
|
replication ุฃู enzymatically modified surface |
|
|
|
612 |
|
00:55:10,290 --> 00:55:13,910 |
|
membrane tumor cell ุฃู extract of antigen from the |
|
|
|
613 |
|
00:55:13,910 --> 00:55:18,110 |
|
surface of tumor cell ูููุง ุนุจุงุฑุฉ ุนู antigen ููู |
|
|
|
614 |
|
00:55:18,110 --> 00:55:22,840 |
|
ู
ูุนูููุจุนูุด ุฃูู ู
ุงูุตุงุฑุด ููู ุงููู ุงููู ูู |
|
|
|
615 |
|
00:55:22,840 --> 00:55:28,380 |
|
replication ูู ุงู .. ูุจุงูุชุงูู ูู ุจุฑุน ุงูู energy |
|
|
|
616 |
|
00:55:28,380 --> 00:55:34,980 |
|
ุจูุนุทู ุนุณุงุณู ูููู
ุงูุฌูุงุฒ ุงูู
ูุงุนู ุนูุฏ ุงูุฅูุณุงู |
|
|
|
617 |
|
00:55:34,980 --> 00:55:37,880 |
|
despite success in protection of experimental |
|
|
|
618 |
|
00:55:37,880 --> 00:55:42,720 |
|
animal ูู ุงูู animal ู
ุงุดู efficacy of menopreflexes |
|
|
|
619 |
|
00:55:42,720 --> 00:55:44,040 |
|
for protection of human |
|
|
|
620 |
|
00:55:51,920 --> 00:55:57,020 |
|
ุฃู ุญููููุฉ ุนูู ุงูู human ุจุงููุณุจุฉ ููุชุนุงู
ู |
|
|
|
621 |
|
00:55:57,020 --> 00:56:01,600 |
|
ุงูู ุจุฑููููุงูุชููู ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู |
|
|
|
622 |
|
00:56:01,600 --> 00:56:05,840 |
|
ุงูู human ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู ุงูู human |
|
|
|
623 |
|
00:56:05,840 --> 00:56:05,920 |
|
ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู |
|
|
|
624 |
|
00:56:05,920 --> 00:56:06,100 |
|
ุงูู human ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู ุงูู human |
|
|
|
625 |
|
00:56:06,100 --> 00:56:09,740 |
|
ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู ุงูู human ุจุดูู |
|
|
|
626 |
|
00:56:09,740 --> 00:56:10,620 |
|
ุงููููู
ุงู ุจูุด |
|
|